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ABSTRACT 
Anna P. Deryabina: An Assessment of Needle-Syringe Program For People Who Inject Drugs in the 
Kyrgyz Republic   
(Under the direction of Sandra Greene) 
 The study aimed at 1) describing and assessing the scope and the quality of the NSP in the 
Kyrgyz Republic in comparison to international standards; 2) comparing effectiveness of facility, 
NGO and pharmacy based NSPs; 3) identifying barriers and facilitators that affect PWID uptake of 
services, and 4) developing recommendations to improve NSP implementation. 
 The study showed that although NSP implementation in the Kyrgyz Republic was supported 
by the national legislation, certain standards for NSP policy and legislation were overlooked and 
NSP funding was fully dependent on external aid. Geographical availability of NSP was limited. Non-
injecting sex partners of PWID were rarely involved.  Only a few NSP sites had formalized referral 
pathways to other health services and the existing referrals were poorly documented. The 
distribution of low dead space syringes recommended for distribution by NSPs was limited.  
 Although facility-based NSPs provided a greater number of clean syringes to a greater 
number of clients compared with other modalities, they were serving different PWID in different 
locations and therefore cannot be really compared.  None of the NSPs were effective in providing 
and properly documenting HIV counseling and testing services to PWID and their sex partners.  All 
NSPs were characterized as providing minimal or no linkage and referral of PWID in linking and 
referring PWID to other health services.   
 Access of PWID to NSP was limited due to fear of police encounters, inconvenient hours of 
operation, unfriendly attitudes by NSP staff and a limited menu of supplies available to clients. At 
the same time, availability of outreach services and provision of additional health services were 
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highly valued by PWID.   
 The findings suggest a need for further NSP services quality improvement and reduction of 
barriers that negatively affect PWID uptake of NSP services. To achieve decreases in HIV incidence, 
NSPs should ensure regular HIV testing of clients and serve as a referral mechanism for PWID 
access to substance use treatment and HIV care and treatment. 
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CHAPTER I: INTRODUCTION 
Background 
The Kyrgyz Republic is located in Central Asia, one of the few regions in the world where 
the HIV epidemic is still growing.  As of December 31, 2014 there were 5,504 cumulative HIV cases 
confirmed in the Kyrgyz Republic.  According to the country-reported Global AIDS Response 
Progress Report data and Spectrum1 estimates, there are more than 9,300 (7100-12,000) people 
living with HIV (PLWH) in the Kyrgyz Republic (UNAIDS, 2014).  
 Sharing of needles and syringes and drug preparation materials, as well as use of preloaded 
drug solutions are important risk factors for infection acquisition and transmission among PWID 
(CDC, 2012).  Injection drug use is the reported mode of transmission for almost 60% of all 
confirmed HIV infections in the Kyrgyz Republic. Based on estimates from the Republican AIDS 
Center, in 2013, there were approximately 25,500 people who injected drugs2 (PWID) in the Kyrgyz 
Republic, and the prevalence of HIV among PWID varied from 6% -17% in different regions of the 
country (Country HIV Program Progress Report – 2014, in Russian).  
 Availability of syringe distribution programs was shown to have a substantial impact in 
reducing unsafe injecting practices (Bluthenthal, Kral, Gee, Erringer, & Edlin, 2000).  Among HIV-
prevention interventions for PWID, Needle and Syringe Programs3 (NSP) are probably the most 
                                                             
1Population projection software developed by the United Nations Program on HIV/AIDS (UNAIDS) Reference 
Group on Estimates, Models and Projections to support national estimates and projections. 
 
2Refers to people who inject psychoactive substances, primarily opioids, but also amphetamine-type 
stimulants, cocaine, hypno-sedatives and hallucinogens, for non-medical purposes.  Injection may be through 
intravenous, intramuscular, subcutaneous or other injectable routes.   
 
3Refers to programs in which clean needle and syringes, and other injecting-related paraphernalia are 
provided to people who inject drugs free of charge. 
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studied models.  Peer-review literature from the mid-1980s includes a large number of studies that 
noted a positive effect of NSP on reducing HIV risks from injections, thereby increasing safe 
injections (Abdul-Quader et al., 2013; Degenhardt et al., 2010; Des Jarlais et al., 2007; Palmateer et 
al., 2010).   
 The Kyrgyz Republic has supported implementation of various distribution points for clean 
needles and syringes through NSPs since 1999.  In 2014, there were 40 needle and syringe 
distribution points in the country (MOH, 2014).  Ten thousand PWID (39% of the estimated total 
number of PWID in the Kyrgyz Republic) received clean needles and syringes from these NSP at 
least once during 2013 (UNDP, 2013). According to the national Integrated Bio-Behavioral 
Surveillance (IBBS) of HIV conducted in 2013, 29.4% of the 904 PWID included in the survey 
reported having been reached at least once during the period of July 1, 2012-June 30, 2013 with a 
minimal package of prevention services that included distribution of clean needles and syringes, 
condoms and education on their use, and other informational materials. In addition, 33.5% of the 
interviewed PWID reported being tested for HIV in the last six months and were aware of their test 
results, whether positive and negative (RAC, 2014).  
 Although the Kyrgyz Republic has implemented NSP in a range of Global Fund for AIDS, 
Tuberculosis, and Malaria (GFATM)-supported settings, systematic efforts to track PWID from NSPs 
through the cascade of services are lacking. Furthermore, the NSP programs have never been 
externally evaluated for their quality and cost-effectiveness.  Factors related to quality, such as 
information about the scope of NSP implementation in the Kyrgyz Republic, gaps in NSP service 
delivery, capacity building and funding needs, obstacles and factors that affect PWID uptake and 
coverage with NSP services, are not readily available.  
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Rationale 
 Since 2010, ICAP at Mailman School of Public Health at Columbia University (ICAP) has been 
funded by the President’s Emergency Plan for AIDS Relief (PEPFAR) through the CDC to provide 
tailored technical support to the Ministry of Health of the Kyrgyz Republic to improve the quality of 
the national HIV program, with a primary focus on key populations, particularly PWID.  During 
2011-2014, ICAP completed assessments of the HIV care and treatment system, national opioid 
substitution/maintenance program (OST) program, and the national HIV monitoring and 
evaluation (M&E) system. Results of these assessments contributed to the development and 
implementation of nationwide, tailored quality improvement plans for adult HIV care and 
treatment services, OST programs, and the national HIV M&E system. Considering that NSPs are 
one of three core interventions of a comprehensive HIV prevention program for PWID (the others 
being OST and antiretroviral therapy), the Ministry of Health of the Kyrgyz Republic identified the 
need to conduct a comprehensive assessment of the NSP in the Kyrgyz Republic.    
 At the International AIDS Conference held in Washington, DC in July 2012, Secretary Hillary 
Rodham Clinton announced an investment of $15 million to support Key Populations 
Implementation Science (KPIS) as part of the PEPFAR program. These funds were meant to support 
implementation science projects focused on providing knowledge necessary to implement the most 
effective HIV services for key populations. In the cascade of services described in the KPIS 
announcement as ‘reach-test-treat-retain’, community-level interventions were identified as key to 
facilitating PWID uptake and use of a range of services, starting with voluntary HIV testing and 
facility-based continuum of care services for HIV-positive PWID.   
 Community-based prevention core interventions such as NSP serve as a critical link 
between PWID and their access to additional services along the prevention-treatment continuum. 
These services can include but are not limited to linking and referring PWID to a cascade of services 
–HIV testing and counseling, OST, and antiretroviral therapy (ART). NSP are referred to as part of 
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the HIV prevention and care continuum for PWID to access a range of prevention, care and 
treatment services.  The idea of the comprehensive assessment of needle-syringe programs in the 
Kyrgyz Republic was supported by the KPIS initiative.  Data collected as part of the ICAP-led 
comprehensive assessment of needle-syringe programs in the Kyrgyz Republic were used for the 
secondary analysis within this study.  
Purpose and Aims 
 The purpose of this study was to generate evidence that will support the Ministry of Health 
of the Kyrgyz Republic and local service providers in making decisions to improve implementation 
of the needle-syringe program in the Kyrgyz Republic.  The specific research aims were:  
1) Describe the national needle and syringe program in the Kyrgyz Republic and assess the 
extent to which it adheres to international standards on the National policy and legislation 
related to NSP and NSP service delivery quality specified by WHO, UNODC and UNAIDS. 
2) Compare effectiveness of three NSP service delivery modalities (NGO-based, government 
medical facility based and pharmacy based) in the Kyrgyz Republic in: 
a) reaching, engaging and providing PWID with the means to reduce HIV risks related 
to injecting and sexual behaviors; 
b) ensuring regular HIV testing and counseling of PWID;  
c) linking and referring PWID to STI, OST and ART programs. 
3) Identify barriers and facilitators that affect PWID uptake of NSP services. 
4) Develop recommendations for a plan for change that, if implemented, would increase the 
number of PWID who successfully access NSP in the Kyrgyz Republic.  
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CHAPTER II: LITERATURE REVIEW 
 The key objective of the literature review was to summarize information about existing 
international guidance and recommendations on NSP delivery, comparative effectiveness of 
different modes of NSP delivery in achieving better uptake and access of PWID to the HIV 
prevention, care and treatment continuum of services, as well as potential barriers and mediators 
that could affect access to NSP in the Kyrgyz Republic and around the world.  Specifically, the 
literature review was used to answer the following questions about the NSP in the Kyrgyz Republic 
and around the world:  
 What program elements influence NSP effectiveness in reducing risky injecting practices?  
 What is the impact of different NSP modalities on access and coverage of PWID with HIV 
continuum of care? 
 What are known barriers that affect PWID uptake of NSP services? 
Description of an Effective NSP 
 The need for NSPs, their role in a comprehensive response to HIV among PWID and 
evidence for their effectiveness in reducing risky behaviors that lead to HIV infection can be found 
in many documents developed over the past decade by the UN and other organizations (CDC, 2012; 
Degenhardt et al., 2010; Tilson et al., 2007; WHO, 2007, 2014a). The quality of NSP implementation 
at service level has a direct impact on its impact on the HIV epidemic (Medlin, Balkus, & Padian, 
2008).  In 2007, WHO released a Guide to Starting and Managing NSPs that listed the following key 
elements that distinguish effective NSP: ensure broad coverage; conduct careful assessments of 
client needs; facilitate community mobilization and involvement; provide comprehensive range of 
easy to access services that include different models of NSP delivery, referrals to OST, voluntary HIV 
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testing, diagnosing and treatment of STIs and HIV management including ART; provide range of 
commodities tailored for local needs; involve sexual partners as an effective approach to promote 
sexual and drug HIV risk reduction among PWID (El-Bassel, Shaw, Dasgupta, & Strathdee, 2014); 
implement effective monitoring and evaluation system; provide community-based outreach 
services; ensure that all clients are treated with dignity and sensitivity for cultural and gender-
based differences; use all opportunities to educate PWID about their risks; operate in an enabling 
environment; and is financially sustainable (WHO, 2007).  This list was drawn mainly from 2005 
‘WHO Policy and programming guide for HIV/AIDS prevention and care among injecting drug 
users’ and was prepared using information from key informants’ interviews, literature review and 
examples of existing protocols and standards in use at that time. The idea behind this list was to 
switch the focus from only measuring and quantifying what has been implemented (outputs, for 
example: the number of syringes distributed) to understanding implementation processes that are 
linked to improved outcomes and impact (Medlin et al., 2008). In 2014, WHO used the mentioned 
above list of key elements that distinguish effective NSP to develop Consolidated guidelines on HIV 
prevention, diagnosis, treatment and care for key populations (WHO, 2014a). These guidelines 
bring together all existing guidance relevant to HIV interventions in key populations and serve as 
internationally accepted normative guidance for HIV programs among PWID, including NSP quality 
standards.   
 The importance of coverage is emphasized in the Universal Access approach adopted by 
WHO, UNAIDS and its other partner organizations.  A wide range of definitions is used in the 
existing literature about coverage of interventions among PWID (Sharma, Burrows, & Bluthenthal, 
2007).  The definition of coverage often implies the number of PWID provided with NSP services 
and intensity of contacts between PWID and NSP, including the frequency and regularity of contacts 
and the number of services provided to each client.  Earlier research had mixed conclusions about 
the relations between the regularity of NSP contacts and needle sharing behavior.  Thus, a study 
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from Amsterdam showed that that regular clients of the syringe exchange, when compared with 
other injecting drug users, were less often than other users to share injecting equipment, but this 
difference was not statistically significant (Hartgers, van Ameijden, van den Hoek, & Coutinho, 
1992).  At the same time, a Monte Carlo simulation study showed that the increased frequency of 
NSP attendance had the largest impact on elimination of needle sharing behaviors (Raboud, Boily, 
Rajeswaran, O’Shaughnessy, & Schechter, 2003).  This led to more discussions and research about 
the definition of coverage, which, if reached, could lead to substantial decreases in HIV prevalence.   
A modeling study by Vickerman et al. suggested that the threshold coverage largely depends on the 
frequency that PWID inject and (safely) reuse their syringes, and corresponds to less than four 
syringe-sharing events per PWID per month (Vickerman, Hickman, Rhodes, & Watts, 2006).   WHO, 
UNODC, UNAIDS defines the coverage as the percentage of the estimated number of PWID who 
were reached by NSP at least once per month over the specified period and recommends that 
programs target to regularly reach at least 60% of the estimated number of PWID (WHO, 2012). 
This target was based on a retrospective analysis of coverage required to reverse HIV epidemics in 
high-income (Hyshka, Strathdee, Wood, & Kerr, 2012) and middle and low-income countries (Des 
Jarlais, Feelemyer, Modi, Abdul-Quader, & Hagan, 2013) and is accepted as the globally 
recommended threshold for effective NSP coverage.  
 Coverage depends on geographical availability of services. WHO Technical Guidelines 
recommend that NSP are present in at least 80% of all sites where injecting drug use occurs (WHO, 
2014a).  Research from other settings has showed that PWID who reside in close proximity to NSPs 
are more likely to consistently access services and are less likely to share injection equipment (S. 
Allen, Ruiz, & O'Rourke, 2015; Bruneau, Daniel, Kestens, Zang, & Genereux, 2008; Hutchinson, 
Taylor, Goldberg, & Gruer, 2000).   
 The levels of syringe distribution per each PWID per year also relate to coverage and has its 
impact on HIV transmission.   Several studies showed that NSPs need to distribute on average 200 
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needles-syringes per PWID per year in order to be effective in decreasing HIV incidence (Abdul-
Quader et al., 2013; Des Jarlais et al., 2013; Vickerman et al., 2006).  This target was further 
accepted as the globally recommended standard for NSPs (WHO, 2012).   
 Not only the quantity, but also the type of syringes distributed to PWID is important to 
control the epidemic. Changing distribution from high dead space to low dead space syringes 
among PWID can reverse HIV epidemics (Vickerman, Martin, & Hickman, 2013; Zule, 2012; Zule, 
Desmond, & Neff, 2002).   Thus, WHO recommends NSPs to provide syringes that retain on average 
10 times less blood than conventional syringes (referred to as “low-dead space” syringes, or LDSS) 
(WHO, 2014a).  This recommendation was made based on the results of laboratory experiments 
that simulated the process of injection and showed that high dead space syringes retained over 
1000 times more blood than that retained by low dead space syringes (Bobashev & Zule, 2010) as 
well as the review of ecological data that showed relatively low HIV prevalence in cities where 
PWID predominantly used low dead space syringes  (Vickerman et al., 2013; Walsh, Verster, 
Rodolph, & Akl, 2014). 
 PWID are commonly discriminated, marginalized and have limited access to health services 
due to the illegality of drug use.   Therefore, national laws and policies are critical enablers that 
influence effectiveness of HIV programs at different levels.  WHO, UNODS and UNAIDS Technical 
Guide lists 18 standards and program features that need to be included into the national policy and 
legislation relating to NSP in order for the programs to be effective (WHO, 2012). This list has been 
developed through a process of consultations with international experts in the field and includes 
provisions on the legal status of NSP in the country, sustainability of its funding, involvement of 
community representatives and NSP clients in program planning, management and 
implementation, range of delivery models and client confidentiality issues.      
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Impact on Access and Coverage of PWID with HIV Continuum of Care 
 Distribution of needles and syringes is the primary role of NSP, however for many PWID 
needle and syringe distribution programs remain to be the first and sometimes the only point of 
contact to health care services, including substance use treatment and OST, diagnosing and 
treatment of sexually transmitted infections (STI) and HIV care and treatment (Cisneros, Douaihy, 
& Kirisci, 2009; M. M. Islam et al., 2013; Kidorf & King, 2008).  
 Continuum of HIV care for PWID includes timely and regular HIV testing and counseling 
(HTC), early enrollment in HIV care and initiation of ART for HIV-positive people and adherence to 
prescribed treatment regimen.  Targeted periodic HTC and immediate ART combined with other 
interventions can improve the quality of life for PWID and lead to decreased HIV transmission 
(Kato et al., 2013). Although there is paucity of data on the efficacy of antiretroviral therapy (ART) 
for prevention in PWID, evidence from the general population shows that treating HIV-infected 
persons also significantly reduces their risk of transmitting the infection to sex partners who did 
not have the virus (Cohen et al., 2011; McNairy, Deryabina, Hoos, & El-Sadr, 2013). In addition, 
there is insufficient evidence that any single intervention is effective enough to guarantee HIV 
control but the aggregate effect of several interventions is suggested. Sterile needle and syringe 
availability has to be supported by a range of complementary measures, such as opioid 
maintenance therapy, ARV and effective HIV testing and counseling (Amundsen, 2006; Degenhardt 
et al., 2010).  
 The availability of published literature on the effectiveness of the needle and syringe 
programs to ensure better access of PWID to continuum of HIV care, including HIV testing and ART, 
was disappointing as only few studies reviewed discussed access of NSP clients to HIV testing and 
HIV care and treatment. A WHO review stated that there is reasonable evidence that NSP can 
increase recruitment into drug treatment and possibly also into primary health care (WHO, 2004). 
A study from Iran showed that outreach NSP model can be effective in increasing the rates of HIV 
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testing among PWID (Nazari et al., 2016).  Training and active engagement of pharmacists in NSP 
activities was proven to be effective in increasing access of PWID to the healthcare system and HIV 
and STI testing and facilitating referrals of NSP clients to the methadone maintenance treatment 
program (Bonnet, 2006; Rudolph et al., 2010).   
 Comparative advantages of different NSP modalities were mixed and also not sufficiently 
discussed in the literature.  Results of a systematic literature review that included evidence from 
two randomized controls trials to suggest that NSP setting does not affect injection risk behaviors 
(Jones, Pickering, Sumnall, McVeigh, & Bellis, 2010) as well as other studies showing that needle 
sharing depends on other factors, such as syringe supply and access, and PWID social network 
relationships ((Shaw, Shah, Jolly, & Wylie, 2007; Wood et al., 2002).  A randomized controlled study 
in the US showed that PWID who attended a hospital-based NSP had improved access to health care 
services compared to those attending community-based NSPs (Masson et al., 2007).   At the same 
time there was evidence that syringe distribution through vending machines or mobile exchange 
points are more effective approaches to reaching younger PWID and PWID with higher risks, who 
typically avoid NSPs and pharmacies (Jones et al., 2010; Kermode, Songput, Sono, Jamir, & Devine, 
2012; McDonald, 2009; Obadia, Feroni, Perrin, Vlahov, & Moatti, 1999).  A systematic review of 
three core reviews consisting of 43 primary studies from before 2007 conducted by Palmateer et al 
concluded that there is tentative evidence that pharmacy availability of sterile injecting equipment 
provides specific benefits in declining syringe sharing among PWID in addition to those derived 
from NSPs’. And while as mentioned above vending machines could be effective in reaching PWID, 
especially those who are younger, the study by Palmateer et al showed insufficient evidence of the 
effectiveness of vending machines in reducing injecting risk behaviors.  Therefore, it is reasonable 
to state that pharmacy-based distribution, outreach services, including secondary exchange, and 
vending machines provide specific benefits in addition to those derived from fixed-NSPs and shall 
be considered as complementary to primary NSPs (Bryant et al., 2010; Irwin, Karchevsky, Heimer, 
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& Badrieva, 2006; M. Islam, Wodak, & Conigrave, 2008; Kral, Anderson, Flynn, & Bluthenthal, 2004; 
WHO, 2004).  According to the report from one assessment of NSPs in Australia conducted by 
Health Outcomes International in 2007-2008 (Communicable Disease Control Directorate (2008)), 
the capacity of “stand-alone”/primary NSP to provide information, education and referral services 
is variable and highly depends on whether staff were trained to provide PWID-friendly services and 
the existing agreements between the NSP and local providers of health services.    
Barriers that Affect PWID Uptake of NSP Services 
Stigma, discrimination, and criminalization continue to pose significant barriers to HIV 
program access for PWID, in increasing access to healthcare (Ti & Kerr, 2013).  Criminalization of 
possession of illicit substances and injecting equipment often forces PWID in many settings to hide 
their equipment and engage in unsafe injecting practices (Stoicescu, 2012) and was consistently 
reported as a common barrier to NSP utilization by several studies from around the world 
(Beletsky et al., 2014; Koo et al., 2015; Martinez et al., 2007; Rich, Strong, Towe, & McKenzie, 1999; 
Spicer et al., 2011; WHO, 2014a).  
In many places, PWID also experience stigma and discrimination from healthcare workers, 
or receive services that are not delivered in a culturally sensitive and PWID-friendly way (Stoicescu, 
2012).   Even in countries with well-developed harm reduction policies and services, PWID are 
often reluctant to disclose their injecting and have limited access to health services due to the real 
perceived fear of stigma by health workers (M. M. Islam et al., 2013).   
 PWID have been reported to have heightened sensitivity to discrimination and notions of 
identity and legitimacy are inextricably bound with the stigmatization of drug use, shaping PWID 
experiences and trust in NSPs (Cattan, Bagnall, Akhionbare, & Burrell, 2009; Treloar, Rance, Yates, 
& Mao, 2015; Wilson, Brener, Mao, & Treloar, 2014). Lack of trust between clients and NSP staff 
that have no personal experience injecting drugs was reported as another significant obstacle for 
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the delivery of effective NSP services for people who inject drugs potentially leading to injecting 
risk practices (Wilson et al., 2014).  
 The literature search identified only one peer-reviewed publication with data from 2007 
and 2008 that discussed multiple, interrelated access barriers that PWID face when trying to access 
different types of government and NGO-run HIV services including NSP and treatment and drugs 
treatment in the Kyrgyz Republic (Spicer et al., 2011).  According to the study, barriers to accessing 
HIV services included: the interrelated problems of stigma and discrimination, compounded by 
poor levels of information about HIV/AIDS among PWID and society as a whole; the criminalization 
of drug use and discriminatory practices among law enforcement officers and service providers; 
and gaps in the regular supply of commodities. In the study, clients of HIV programs reported that 
client referrals were in practice inconsistently applied and frequently consisted of informal 
signposting rather than formalized referral across government and NGO providers. 
Conclusion 
 The existing literature provides sufficient guidance on indicators that can be used to assess 
the overall quality of NSP implementation, including NSP related policy and legislation, as well as to 
compare effectiveness of different NSP modalities.  Thus, key prerequisites of a successful NSP 
include:  
Input  
 The program has secured long-term funding 
 The NSP implementation is supported by the national policy and legislation  
 The NSP are present in at least 80% of all locations where drug injecting is known to 
occur.  
 The NSP workforce is well trained and supervised 
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Process  
 The program actively involves PWID in planning and delivery of NSP services 
 The service regularly seeks anonymous feedback from clients 
 The NSP is situated in a location known to be accessible to PWID 
 The program employs a range of NSP service delivery models to maximize reach 
 The NSP service maintains confidentiality 
 The NSP service is low-threshold and does not require PWID to meet specific criteria 
 The service provides a range of injecting equipment that is appropriate for local 
injecting practices and substances and includes low dead space syringes/needles. 
 The program has no limits on the quantity of injecting equipment provided 
 The NSP return of used injecting equipment is not a prerequisite for clients to receive 
new injecting equipment.  
 The NSP services provide targeted information, education and communication, 
including prevention of HIV transmission during sex and overdose prevention and 
involves sex partners of PWID 
 Formalized referral pathways between NSPs and other relevant service providers are 
established and NSP clients are referred to these services as appropriate  
Output  
 The NSP covers at least 60% of the estimated number of PWID in the catchment area 
with at least 200 needles/syringes and 100 condoms per PWID per year  
 All NSP clients are tested for HIV 
 All HIV-positive NSP clients are linked to HIV care and treatment programs  
 Comparative advantages of different NSP modalities were not sufficiently discussed in the 
literature.  The overall conclusion from the literature review is that pharmacy-based distribution, 
outreach services, including secondary exchange, and vending machines provide certain specific 
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benefits in addition to those derived from fixed-NSPs and shall be considered as complementary to 
primary NSPs. The capacity of primary NSPs to provide information, education and referral services 
highly depends on whether staff were trained to provide PWID-friendly services and whether the 
NSP has formalized referral agreements with local providers of health services.  
 There were sufficient data about barriers that affect PWID access to NSP in different parts of 
the world. Key barriers include: criminalization of drug use and discriminatory practices by police, 
stigma and discrimination of PWID by healthcare workers, and lack of trust between PWID and NSP 
staff that had no personal experience injecting.  However, there were no studies published that 
would describe or assess implementation of NSP programs in the Kyrgyz Republic, except for one 
study from almost 10 years ago that described barriers that PWID face when trying to access 
different types of government and NGO-run HIV services.  The impact of NSP on access and 
coverage of PWID with HIV continuum of care is also not clear from the existing literature.  
 Considering this, there is a need to understand the potential impact of NSP on the ability of 
PWID to access HIV care, namely to undergo HIV testing and counseling, timely access to HIV care 
and treatment services, remain in HIV care, and adhere to ART.  If found effective, these data on NSP 
impact on PWID access to HIV continuum of care can be used to advocate for broader availability of 
NSP, as well as to provide useful information for NSP managers to improve their programs and 
make them more effective in providing services to HIV-positive PWID.  
 HIV in Central Asia including in the Kyrgyz Republic is still primarily transmitted among 
people who inject drugs through sharing needles. Syringe distribution as an effective HIV 
prevention method is supported by a myriad of mainstream medical, scientific and government 
entities around the world and in the Kyrgyz Republic. A need exists in the literature to develop a 
complete understanding of the scope and effectiveness of needle and syringe programs in the 
Kyrgyz Republic.  To ensure effectiveness of HIV prevention efforts, we need to significantly 
improve access of PWID to NSP services and other evidence-based effective HIV prevention 
15 
interventions, such as opioid substitution therapy and antiretroviral therapy.  This would also 
require an understanding on how to utilize NSP not only to improve access of PWID to clean 
injecting equipment and basic HIV information, but also to facilitate their access HIV testing and 
treatment services.
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CHAPTER III: METHODOLOGY 
Study Design and Statistical Procedures 
Summary Description 
 The study was conducted using a convergent parallel mixed methods study design 
(Creswell & Clark, 2011).  The data were collected during July – November 2015 using the following 
data collection methodologies:  
1. Review of relevant documents (NSP-related policies, other NSP-related program 
implementation and research reports and standard operating procedures); 
2. Secondary analysis of data received during in-depth interviews with NSP program 
managers;  
3. Secondary analysis of data received during focus-group discussions with PWID; 
4. NSP programmatic data review.  
As described earlier in the Introduction section above the purpose of this study was to generate 
evidence that will support the Ministry of Health of the Kyrgyz Republic and local service providers 
in making decisions to improve implementation of the needle-syringe program in the Kyrgyz 
Republic.  The specific research aims were:  
1. Describe the national needle and syringe program in the Kyrgyz Republic and assess the 
extent to which it adheres to international standards on the National policy and 
legislation related to NSP and NSP service delivery quality specified by WHO, UNODC 
and UNAIDS. 
2. Compare effectiveness of three NSP service delivery modalities (NGO-based, 
government medical facility based and pharmacy based) in the Kyrgyz Republic in 
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reaching, engaging and providing PWID with the means to reduce HIV risks related to 
injecting and sexual behaviors; ensuring regular HIV testing and counseling of PWID; 
and linking and referring PWID to STI, OST and ART programs. 
3. Identify barriers and facilitators that affect PWID uptake of NSP services. 
4. Develop recommendations for a plan for change that, if implemented, would increase 
the number of PWID who successfully access NSP in the Kyrgyz Republic.  
 The use of mixed methods enabled me to adopt a pluralistic stance of gathering different 
types of data to best address four research aims listed above (Bamberger, Rugh, & Mabry, 2011). As 
one data source would have been insufficient to meet the research aims, qualitative and 
quantitative data were collected in the same phase to provide multiple perspectives and stance 
(unbiased NSP program statistics and qualitative data collected through interviews and focus group 
discussions). The use of mixed methods in this study was further justified by several reasons 
(Bryman, 2008), including:  
1. Triangulation. This multi-pronged approach facilitated gathering of data from a variety 
of sources that were combined and triangulated to provide a truly comprehensive 
picture of NSP implementation in the country. 
2. Offset: The use of mixed methods provided strengths that offset the individual 
weaknesses of qualitative and quantitative research.  Thus, NSP program data review 
alone was unable to provide clarity about the context in which that data was collected. 
On the other hand, data from individual interviews and focus group discussions are 
usually prone to biases and is hard to generalize. 
3. Process: Document reviews provided information on how systems and functions were 
expected to be in place. Data from in-depth interviews with NSP program managers 
contributed to understanding how the systems and functions are being implemented. 
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4. Different research aims:  As shown above, this study included several different research 
aims that required the use of different data sources and methodologies.  
5. Context:  combination of methods was rationalized in terms of individual interviews and 
focus group discussions providing contextual understanding coupled with externally 
valid findings of program data and literature review. 
 Specifically, information received from the document review and in-depth interviews with 
key stakeholders and NSP program managers was used to address the first aim of the study and 
describe the existing NSP in the Kyrgyz Republic.  NSP program data, data from the document 
review and information from the qualitative interviews and focus groups with PWID were used to 
compare effectiveness of three NSP types. Barriers and facilitators that affect PWID uptake of NSP 
services were assessed based on the information received from PWID during focus group 
discussions and in-depth interviews with NSP managers.  Recommendations for a plan for change, 
that, if implemented would improve the quality of NSP implementation in the Kyrgyz Republic was 
developed based on the feedback received from key stakeholders, NSP managers and PWID who 
participated in the focus group discussions.    
Study Settings 
 This study focused on facility and NGO-based fixed NSP sites, as well as pharmacy-based 
NSP located in the six largest purposefully sampled cities on the drug trafficking route in the south 
and north of the country (Bishkek city, Osh and Kara-Suu cities in Osh oblast, Kant, Kara-Balta and 
Sokoluk in Chui oblast).  Because of logistical issues and a protracted process of entry approvals, 
NSPs located in penitentiary facilities were not included.  
For the purpose of this study, a location was considered a “site” if the following conditions 
were met (adapted from WHO, UNODC, UNAIDS Technical Guide, 2012):  
 It is a fixed site that has frequent (opened either daily or at least five days per week) and 
fixed hours of operation. 
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 Includes pharmacy sites providing needles and syringes at no cost to the client. Those 
that only sell needles and syringes were not included. 
 Across the three types of sites, a total of 19 NSP sites were assessed (Table 1). The three 
different types of NSP sites are NGO-based, government facility-based and pharmacy-based. 
Because all program data on pharmacy-based NSP were aggregated, all eight pharmacy-based NSP 
sites were included in the assessment, but considered as one site, thus resulting in a total of 12 NSP 
sites that were included in the assessment.  The selected sites included all NSP sites located in Osh 
City (two sites) and Karasuu District in Osh Region (one site), as well as Kant City (one site), Kara-
Balta City (two sites), and Sokuluk City (two sites) in Chui Region.  In Bishkek, the assessment 
included one randomly selected site out of the two NGO-based sites, all seven sites that 
implemented pharmacy-based distribution of needles and syringes, and two sites randomly 
selected out of eight sites located at the Family Medicine Centers (FMC). Random sampling was 
performed using MS Excel. 
Table 1. Study sites 
City Implementing/managing partner 
NGO-based NSPs 
Bishkek NGO “Aman plus” 
Osh NGO “Parents against drugs” 
Karasuu NGO “Parents against drugs” 
Kara-Balta NGO “Aman plus” 
Kant NGO “Anti-stigma” 
Government facility-based NSPs 
Bishkek FMС #3 
Bishkek FMC #8 
Osh Interoblast Narcology Center 
Kara-Balta Oblast FMC 
Sokuluk FMC Sokuluk 
Sokuluk Group of Family Physicians “Manas” 
Pharmacy-based NSPs 
Bishkek & Kant 8 sites managed as NGO “Sotsium”  
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Data Collection Procedures 
Document review   
 The document review aimed to obtain information on the following: policy and legal 
environments, geographical availability of NSP and the spectrum of services available, funding, 
human, material and information resources available and used for the program, sustainability of 
resources, systems for procurement and supply management, including stock-out management, 
monitoring and evaluation system, decision making schemes as they relate to design and 
implementation of NSP services, service coverage, available capacity building resources, linkages 
and collaboration between programs. 
 Compliance of the national NSP policy and legislation to international standards was 
assessed using the National Policy Checklist developed by WHO, UNODC and UNAIDS (WHO, 
2014a).  The policy checklist has been developed collaboratively by the UN agencies through a 
process of consultations with international experts in the field.  
In-depth interviews with NSP program managers  
 The study included a secondary analysis of qualitative data collected by ICAP at Columbia 
University through in-depth interviews with NSP staff using an interview guide shown in Appendix 
1.  Specifically, I have used de-identified transcripts of individual interviews with all NSP managers 
working in NSP sites selected for the study. The decision to limit the analysis to NSP managers only 
was justified by the fact that NSP managers are usually the most experienced and knowledgeable of 
NSP implementation aspects among all NSP staff and are in a position to make changes and take 
actions.  Re-analysis of data from interviews with NSP managers allowed me to collect more 
detailed information on the NSP processes, program quality, staffing, including training on HIV 
issues and risk reduction, monitoring of program activities, availability of on-site services, such as 
HIV rapid testing, ART counseling and adherence support, social support services, linkages with 
HIV and other health services, and existing challenges.  The idea behind the secondary analysis of 
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interviews with NSP managers was to learn what they need to have and to know to improve 
implementation of their NSP programs (Patton, 2015).  
Focus-group discussions with PWID (NSP users and non-NSP users) 
 The study included a secondary analysis of qualitative data collected by ICAP at Columbia 
University during focus-group discussions with PWID residing in study sites using focus group 
discussion guide (Appendix 2 &3). The study included transcripts from five focus groups, including 
focus groups conducted in two largest cities (Bishkek in the north and Osh in the south) and two 
regional centers (Tokmok in the north and Kara-Suu in the in south) with both clients of NSP and 
those who do not use NSP services and a separate focus group conducted with female only PWID in 
Bishkek, both clients of NSP and those who do not use NSP services.  Data from the focus group 
discussions with PWID were used to identify and discuss key challenges to access NSP services and 
quality of services provided at different NSPs, and factors that could improve access to NSPs.  
NSP programmatic data review 
 Data from the UNDP-supported Management Information System (MIS) used for monitoring 
of NSP activities were reviewed to collect data on demographics, utilization, coverage and quality. 
Complete de-identified datasets covering the period of January 1, 2014 – June 30, 2015 were used 
to assess NSP effectiveness in reaching, engaging and providing PWID with the means to reduce HIV 
risks related to injecting and sexual behaviors; ensuring regular HIV testing and counseling of 
PWID; and linking and referring PWID to OST programs, TB screening and treatment, and ART 
programs.  A dataset covering the period of January 1, 2014 – December 31, 2014 was used to 
collect information for all the annual indicators, including number of needles/syringes and 
condoms distributed per PWID in the last 12 months and number of PWID who were reached by an 
NSP at least once in the 12 months.  Coverage and referral indicators were calculated based on the 
dataset for the period January 1, 2015 – June 20, 2015.  Technical capabilities of the MIS did not 
allow extracting annual indicators for the period July 1, 2014 – June 30, 2015.  An MS Excel 
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summary table (Appendix 4) developed for this study was completed for each NSP visited by 
abstracting data from the site-level aggregated client database or program reports. For analysis, all 
Excel data were transferred to Stata SE13.  
Description of the Sample 
Document review   
As part of this study I have reviewed all available relevant written documents, protocols, 
reports and standard operating procedures (SOPs) relating to provision of NSP including:  
 National policies related to NSP implementation;  
 NSP program implementation manuals and reports;  
 NSP program monitoring reports and official statistical reports of the Ministry of Health 
and the GFATM 
 National reports on the results of the national IBBS and PWID population size 
estimation.  
In-depth interviews with NSP program managers  
 The study included 14 interviews: 11 interviews with all NSP site-level program managers 
working in selected NGO and facility-based sites, an NSP coordinator at the Republican Narcology 
Center and two managers responsible for the pharmacy-based NSP at NGO “Sotsium”.  
Focus-group discussions with PWID (NSP users and non-NSP users) 
 The total number of focus group participants was 53, including 20 females (38%) and 33 
males (62%), some of whom were NSP clients, while others were not. The latter PWID typically 
purchased needles and syringes from local pharmacies rather than obtain them free of charge at 
NSP sites and were invited to participate in the focus group discussion by local NGOs working with 
PWID. Most (58%) of focus group participants had been injecting drugs for more than 10 years 
(Table 2).  
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 During the past two months, most (78%) of focus group participants used NSP services, 
while 22% did not use any NSP services in the past two months and only purchased needles and 
syringes from the local pharmacies.  During the two months prior to the focus group discussion, 
most PWID, regardless of whether or not they were NSP clients, either got their syringes from the 
outreach worker (54%) and/or purchased them from the pharmacy (44%) (Table 3). 
Table 2.   Demographic and behavioral characteristics of focus group participants (N=53) 
Characteristic N % 
Gender 
Male 
Female 
 
33 
20 
 
62 
38 
Age 
≤25 
26-35 
36-45 
>45 
 
2 
15 
29 
7 
 
4 
28 
55 
13 
Number of years injecting drugs 
<1 
1-5 
6-10 
>10 
2 
13 
8 
30 
4 
24 
15 
57 
 
Table 3.  Sources of clean needles/syringes during the past two months among the PWID 
who were focus group participants  
 Number of responses from 
focus group participants 
Percentage of the total 
number of focus group 
participants (%) 
Received syringes from an NSP 
located at the family health center 
5 9 
Received syringes from an NSP 
located at the NGO 
17 32 
Received syringes free of charge in 
exchange for the voucher in the 
pharmacy 
4 7 
Received syringes from the 
outreach worker 
29 54 
Purchased clean syringes from the 
pharmacy 
23 44 
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NSP programmatic data review 
 Also, this study included collection and analysis of data aggregated across all individual 
client records included in the MIS used for monitoring of NSP activities in the Kyrgyz Republic since 
2007.  The aggregated dataset used for program review included 8,554 records of clients reached 
during 2014, 7,249 records of clients reached during the first six months of 2015, and covered all 
clients that received NSP services during 2014 (Table 4). It is important to note that since any NSP 
client could have received NSP services at more than one location, especially in Bishkek, the total 
number of clients could include duplicated users.    
Table 4.  Number of individual client records aggregated by site for program data review, by 
site 
City Implementing/managing 
partner 
Number NSP clients 
reported as reached 
at least once during 
Jan 1, 2014 – Dec 31, 
2014 
Number NSP clients 
reported as reached 
at least once during 
Jan 1, 2015 – Jun 30, 
2015 
NGO-based NSPs 
Bishkek NGO “Aman plus” 615 710 
Osh NGO “Parents against drugs” 2689 2019 
Karasuu NGO “Parents against drugs” 692 404 
Kara-
Balta 
NGO “Aman plus” 483 472 
Kant NGO “Anti-stigma” 926 945 
Government facility-based NSPs 
Bishkek FMС #3 595 681 
Bishkek FMC #8 622 483 
Osh Interoblast Narcology Center 249 249 
Kara-
Balta 
Oblast FMC 231 216 
Sokuluk FMC Sokuluk 300 359 
Sokuluk Group of Family Physicians 
“Manas” 
145 111 
Pharmacy-based NSPs 
Bishkek 
& Kant 
8 sites managed as NGO 
“Sotsium”  
1007 600 
TOTAL 
 8554 7249 
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Human Subjects Protection and Confidentiality 
 The dissertation proposal was reviewed and approved by the University of North Carolina’s 
Institutional Review Board (IRB) and the IRB at the Ministry of Health of the Kyrgyz Republic.  
 No personal information from respondents that participated in the focus group discussions 
or individual interviews with NSP managers was collected as part of this study.  For the secondary 
analysis the study used transcripts of fully de-identified audio records.  Program data review 
included analysis of aggregated program reports.  
 All data were stored on a password-protected computer. Destruction of the data collected 
for this dissertation will be conducted in accordance of federal guidelines for the maintenance of 
federal records. 
Data Analysis 
 As stated above information was collected from different sources using a mix of methods.  
Considering the convergent design of the study qualitative and quantitative data were analyzed 
independently and two strands were mixed when drawing conclusions during the overall 
interpretation of the study results. During the final merging steps of the analysis, results received 
using different methods were interpreted to understand to what extent and in what ways results 
collected using different methodologies converge, diverge from each other, relate to each other or 
combine to create a better understanding of each study finding. Specifically, information was 
triangulated to describe the extent to which the overall NSP in the Kyrgyz Republic corresponds 
with the international recommendations (WHO, 2007, 2014b) and to identify factors that improve 
uptake and access of NSP for PWID, as well as coverage of HIV prevention services (HIV testing, 
linkage to OST, TB and ART).  
 Statistical data analysis of the quantitative data collected during programmatic data review 
was conducted in Stata SE13. Descriptive statistics and stratified analysis were conducted for the 
overall study and by modality. NSPs included in the assessment were classified into groups to 
26 
perform a one-way ANOVA test. If there was a statistically significant difference between groups, as 
determined by a one-way ANOVA, a Tukey post-hoc test was performed.  
 For analysis, qualitative data from individual interviews and FGDs were grouped into 
meaningful patterns and/or themes through content and thematic analysis using NVivo©, a 
software for computer-assisted qualitative data analysis.  In the content analysis the data were 
coded for certain words or content, then patterns were identified and interpreted.  Words, phrases 
or sections of the key informant interviews were reviewed and labeled (either using words or 
symbols). After the data were coded, they were sorted by code to look for patterns.  In the thematic 
analysis, data were grouped into themes. To better analyze and understand each theme I used a 
three-step approach “Describe, compare, relate” (Bazeley, 2009). Conclusions were verified and 
data from qualitative individual interviews and FGD were either linked with data from the 
document review and program data collected as a part of this study to allow for multidimensional 
descriptions and explanations of the observed phenomena or integrated with each other to produce 
a fuller picture of NSP in the Kyrgyz Republic (Mason, 2006). 
 To make sure intended users and key stakeholders were engaged in interpretation of 
results, and increase users understanding and buy-in (Patton, 2015) preliminary findings were 
discussed with the wide range of national and international partners working with PWID in the 
Kyrgyz Republic.  
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CHAPTER IV: RESULTS 
 Results are presented in three sections below, by study aims.   The first section describes 
the national needle and syringe program in the Kyrgyz Republic and how its planning and 
implementation adheres to international recommended minimum standards.  The second section 
compares effectiveness of different NSP modalities, including NGO-based NSPs, NSPs run by the 
government medical facilities and pharmacy-based NSPs.  The third section explores barriers and 
facilitators that affect PWID uptake of NSP services.  
Aim 1: Describe the existing NSP in the Kyrgyz Republic and assess the extent to which it 
adheres to international standards. 
 The Needle and Syringe Program has been implemented in the Kyrgyz Republic since 1999. 
The first two NSP sites were NGO-based and opened in Bishkek and Osh with support from the 
Soros Foundation and UNDP.  In 2000, the Government of the Kyrgyz Republic approved the 
establishment of NSP sites in penitentiary facilities. Since 2009, NSPs have been established at 
government medical facilities, primarily the Family Medicine Centers, as well as at local AIDS 
Centers and a TB clinic in Bishkek. PWID-friendly pharmacy-services or distribution of clean 
needles and syringes through the network of commercial pharmacies began in 2009.  
National Policy and Legislation Related to NSP and Its Compliance to the WHO, UNODC, UNAIDS 
Recommendations  
 Implementation of the NSP in the Kyrgyz Republic is supported by the national legislation 
(both at the policy and regulatory levels) and are no legal limits to the number of syringes that may 
be purchased over-the-counter at pharmacies.  Specifically, several key policy documents include 
provisions related to implementation of NSPs in the Kyrgyz Republic, including:  
28 
 Law on HIV/AIDS in the Kyrgyz Republic from August 13, 2005, article 149 
 Decree of the Government of the Kyrgyz Republic on Endorsement of Antinarcotic Program 
of the Government of the Kyrgyz Republic, dated January 27, 2014, № 54  
 National HIV/AIDS Program for 2012-2016 
 Further, the Kyrgyz Republic is the only country in Central Asia that officially endorsed and 
implemented NSPs in the penitentiary system (Law on Penitentiary System Facilities from August 
12, 2003, № 196).  Although the existing legislation of the Kyrgyz Republic unambiguously supports 
NSPs as legal entities for the distribution of injecting equipment, several stakeholders noted that it 
would be more sustainable if the Antinarcotic Program of the Government of the Kyrgyz Republic, 
including the NSPs, were endorsed by a Law and not the Decree signed by the Prime-Minister, 
which can be subject to change with the change in Government (see comment).  
“If we had a Law on harm reduction services, or on assistance for drug addiction that 
included harm reduction programs, then that Law would have to be implemented. The 
Government would then be required to provide these [NSP] services to people…. If new 
people will come to power, they can cross out these [NSP] costs, and we will not have any 
funds” – staff of an organization that works with PWID. 
 
 In addition to the policy documents, the Kyrgyz Republic also has a number of regulatory 
documents related to NSP implementation. Specifically, on January, 21, 2014, an interagency Order 
on “HIV Prevention in the State Bodies of Internal Affairs (police), Drug Control and Penitentiary 
System” was signed between the Ministry of Internal Affairs, the Ministry of Health, the State 
Service on Drug Control under the Government of the Kyrgyz Republic and the State Penitentiary 
Service under the Government of the Kyrgyz Republic.  This Order includes detailed instruction on 
the prevention of HIV-infection in state bodies of internal affairs (police), drug control and 
penitentiary system that work with vulnerable groups and define the role of the HIV Committee 
that coordinates implementation of HIV prevention activities in penitentiaries, including NSP 
services in prisons, and other law enforcement structures.  
 Also, on January 29, 2009, the Ministry of Health approved the Order #15 on “Opening a 
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Needle and Syringe Exchange Program in Medical Facilities” that included as an appendix the 
“Standards of Harm Reduction Programs and Services for People Who Inject Drugs” (hereafter 
referred to as “NSP Standards”) that are considered as National Guidelines on NSP implementation. 
The NSP Standards serve as national guidelines on NSP implementation and provide detailed 
recommendations on NSP staffing, supply planning and management, record keeping and other 
operational aspects.   NSP Standards are not endorsed by any policy or regulation and, as such, 
cannot be considered as mandatory for implementation.  The National Standards were developed 
under the leadership of the Ministry of Health with active participation of various stakeholders, 
including NGO networks and international organizations.  Most stakeholders interviewed during 
this assessment considered the NSP Standards as an important step for the effective 
implementation of the NSP in the Kyrgyz Republic. 
 In general, the existing NSP policy and legislation in the Kyrgyz Republic could facilitate the 
delivery and effectiveness of NSP interventions.  However, it was lacking several key standards and 
program features recommended by the WHO, UNODC and UNAIDS (Table 5).  
Table 5.  Compliance of the National policy and legislation in the Kyrgyz Republic with the 
WHO, UNODC, UNAIDS recommendations on the National policy and legislation related to 
NSP  
(4 – fully compliant; 2– partially compliant; 0– does not comply with the recommendations).    
Recommendation Status Comment 
Legislation specifically supports 
the distribution of injecting 
equipment through NSPs 
4 The distribution and collection of injecting 
equipment and the operation of NSPs are 
authorized under the law as described in the text 
above. Legislation is not ambiguous on the legal 
status of NSP or on the distribution and collection of 
injecting equipment. 
National police guidelines and 
policy specifically support the 
operation of NSPs 
2 The existing Police guidelines do not explicitly 
stipulate that police activities do not deter or 
prevent PWID from accessing NSPs or from being in 
possession of new or used injecting equipment.  
Nevertheless, police routinely receive training and 
education relating to drug use, HIV and harm 
reduction principals and services. 
Legislation supports the 
provision of NSP services in 
4 The existing legislation supports NSP in prisons.  
The country implements distribution of clean 
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Recommendation Status Comment 
closed settings needles and syringes by prison health staff. 
National policy stipulates PWID 
be actively involved in the 
planning and the delivery of 
NSP services 
0 There are no references or recommendations in the 
existing NSP Standard for NSPs to ensure active 
involvement of PWID in the planning or delivery of 
NSP services. 
National guidelines stipulate 
that NSP services regularly seek 
anonymous feedback from 
clients 
0 National NSP guidelines do not include any 
provisions about mechanisms whereby clients can 
confidentially /anonymously provide feedback on 
the service.  
National guidelines outline 
training and supervision 
requirements for NSP 
workforce 
4 The NSP Standards outline training and supervision 
requirements for the NSP workforce and 
recommend that medical facilities allocate sufficient 
funding for staff training and supervision. Staff 
members are required to be respectful towards 
PWID, have credibility with the target population 
and maintain a non-judgmental attitude towards 
drug users.   
National guidelines stipulate 
that NSPs be located in areas 
known to be accessible to PWID 
4 The NSP Standards also stipulate that NSPs be 
located in areas known to be accessible to PWID, 
located at an appropriate distance from police 
offices to improve acceptability by PWID. 
National policy stipulates that 
NSPs maintain client 
confidentiality 
4 NSPs are required to maintain client confidentiality 
and forego any requirement of PWID to provide 
identification or personal details in order to utilize 
services or obtain injecting equipment. According to 
the NSP Standards, client information shall not be 
shared with other services or law enforcement 
without client consent, unless required by law, for 
example, as part of a criminal investigation, and 
program data collection systems shall not contain 
any clients’ personal or identifiable information. 
National guidance outlines 
systems to prevent NSP 
commodity stock-outs 
0 The NSP Standard does not discuss the need to 
implement a system to prevent commodity stock-
outs.  
National policy stipulates that 
NSP services are “low-
threshold” and do not require 
PWID to meet specific criteria 
in order to access services or 
receive injecting equipment 
4 The NSP Standards stipulate that NSP services are 
“low-threshold” and do not require PWID to meet 
specific criteria in order to access services or 
receive injecting equipment.  Services do not 
restrict access on the basis of minimum age, proof of 
injecting status, proof of residence, gender, HIV 
status, citizenship status, residential status, 
incarceration or criminal history.  
National guidelines stipulate 
that there be no limit on the 
quantity of injecting equipment 
provided 
4 National NSP Standards also stipulate that there be 
no limit on the quantity of injecting equipment 
provided to individual clients.  The Standards, 
however, provide the following recommendations 
on the optimal amount of supplies distributed to 
each PWID in order to ensure that PWID have the 
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Recommendation Status Comment 
means to use clean equipment during every 
instance of drug use: at least two needles/syringes 
per PWID day, or at least 730 syringes per PWID per 
year; at least two alcohol wipes per PWID per day, 
or at least 730 alcohol wipes per PWID per year.  
The guidelines limit the number of condoms 
distributed to each client to no more than 12 
condoms per month or no more than 144 condoms 
per year.  
National guidelines stipulate 
that the return of used injecting 
equipment is not a prerequisite 
for clients to receive new 
injecting equipment 
2 The National NSP Standard does not specifically 
stipulate that the return of used injecting equipment 
as a prerequisite for clients to receive new injecting 
equipment, though NSPs are expected to ensure at 
least 20% return of used injecting equipment for 
fixed NSP sites and at least 50% for sites that have 
mobile units in addition to fixed sites. 
National guidelines stipulate 
that NSPs provide targeted 
information, education and 
communication (IEC), including 
overdose prevention 
2 The National Standards recommend that NSPs 
provide targeted information during mini-sessions 
to clients when they arrive at the NSP sites and 
other informational events with no specification on 
the topics of such mini-sessions. 
National guidelines stipulates 
that NSPs provide a range of 
injecting equipment that is 
appropriate for local injecting 
practices and substances 
injected and that is acceptable 
to the target population 
4 The National NSP Standard stipulates that NSPs 
provide a range of injecting equipment that is 
appropriate for local injecting practices and 
substances injected, and is acceptable to the target 
population.  
National guidelines stipulate 
that formalized referral 
pathways between NSPs and 
other relevant service providers 
are established 
2 Details on the provision of formalized referral 
pathways between NSPs and other relevant service 
providers are described in NSP Standards and the 
“Order of the Ministry of Health #206” from April 
25, 2012. Referral services mentioned in the NSP 
Standards include: treatment for drug dependence 
and OST services; HIV, viral hepatitis B, and TB 
testing, and treatment and care; viral hepatitis 
vaccinations; and sexual health services (including 
STI testing and treatment). 
National guidelines outlines 
monitoring and evaluation of 
NSP programs 
2 The NSP Standard briefly outlines the need and 
suggested processes for monitoring and evaluation 
of NSPs. Specifically, the Standard requires all sites 
to record clients’ unique identifier code (UIC) and 
ensure proper entry of data into a list of program 
specific registers (clients register, supply 
management register, referrals register, etc.).   
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Quality of NSP Service delivery and Its Compliance to the WHO, UNODC, UNAIDS 
Recommendations  
 As discussed in the Literature review above, in 2014 WHO presented a list of quality 
standards that are explicitly linked to reduction of risky behaviors among PWID and decreased HIV 
incidence.   Adherence of NSP program implementation in the Kyrgyz Republic to these 
internationally recommended quality standards at the service level is provided below and is 
summarized in the Table 7 below.  
Standard 1: Long-term funding has been secured to ensure sustainability  
 As mentioned above, the initial funding for the opening of the first NSP sites in the Kyrgyz 
Republic was provided by the Soros Foundation.  From 2002-2004, the program was cost-shared 
between the Soros Foundation and the first GFATM-funded HIV project in the country.  Starting in 
2004 and to date, most NSP funding, including procurement of supplies, is provided by the GFATM.  
In 2003-2004, municipalities of Osh Oblast and Bishkek allocated some of their own health care 
budgets for NSP implementation, which was an important step to demonstrate political 
commitment of the local governments to support NSPs.   Until 2016, Bishkek municipality 
continued to allocate 400,000 soms (approximately USD $5,700) annually for procurement of clean 
needles and syringes for NSP implementation.  In February 2015, the Ministry of Health initiated 
the development of the multi-sectoral technical working group (TWG) to discuss the expansion of 
state funding for HIV prevention activities, including NSPs.  The TWG developed a proposal to shift 
NSP funding to the national budget that is currently being considered by the Government.  
According to the 2014 Kyrgyzstan Country Report on Progress in Implementing the Global 
Response to HIV, the total recorded cost of NSPs in 2013 was USD $1,275,822, which represents 
approximately 0.3% of the overall health expenditures for the same year.  According to the 
developed proposal, in 2016, the Government is considering allocation of 20 million soms 
(approximately USD $282,000) for HIV prevention programs, including two million soms 
(approximately USD $28,000) for the procurement of clean needles and syringes for NSPs.  
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Adherence Status to Standard 1: Not compliant.  
Standard 2: The program employs a range of NSP service delivery models to maximize 
reach  
 The Kyrgyz Republic employed a range of NSP service delivery models, including NSPs 
based in Family Medicine Centers4 (FMC), community-level NSP sites run by local NGOs, NSP sites 
located in penitentiary facilities and NSP sites managed by an NGO, but located in local pharmacies.  
NSPs located in FMC and NGOs also provided outreach services (distribution of clean needles and 
syringes in the community).  For the pharmacy-based distribution, vouchers were distributed to 
PWID by outreach workers employed by an NGO “Sotsium”; these vouchers were then redeemed by 
PWID at participating private pharmacies in exchange for clean needles and syringes.  As of October 
1, 2015 there were 45 NSP sites, including 12 located at government medical facilities, ten managed 
by local NGOs, eight implemented by a local NGO through the network of participating pharmacies, 
and 15 sites located within the correctional system (prisons and jails).   A majority (73%) of all 
syringe distribution during the first six months of 2015 was implemented by NGO-based NSPs 
(Table 6).  
Table 6.   NSPs in the Kyrgyz Republic by proportion of needle and syringe (N&S) 
distribution (Source: UNDP/GFATM PIU 2016) 
NSP type Number of 
outlets/site type 
Percentage of N&S 
distribution (%) 
Number of N&S 
distributed during 
Jan-Jun 2015 
NGO-based 6 73 2,306,679 
Facility-based 13 22 691,491 
Pharmacy-based 8 1 27,735 
Penitentiary -based 15 4 112,624 
Total 42 100 3,138,529 
 
 At the time of the assessment, there were no mobile services or automated vending 
machines dispensing injecting equipment, and all of the services were provided either through 
                                                             
4Family Medicine Centers (FMC) are the government’s primary health care facilities that provide a wide range 
of medical services to the population residing in catchments areas.     
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fixed sites or outreach workers.   
 In addition to NSP sites where clean injecting equipment was available for free, all regions 
(oblasts) and districts (rayons) had pharmacies (mostly privately-owned), where needles and 
syringes were available for purchase.  
Adherence Status got Standard 2: Partially compliant.  
Standard 3: The NSP workforce has received appropriate training and is supervised 
 NSP staff included paid staff, paid outreach workers, and PWID volunteers.  Minimal 
requirements for NSP staffing are described in the NSP Standards.   According to the Standards, the 
number of staff depends on the size of the NSP catchment area and NSP coverage in terms of the 
number of clients.  As such, one full-time nurse was recommended for each site that covers between 
500-1000 PWID and one outreach worker was recommended for every 50 PWID.  Additionally, for 
NGO-based NSPs, a site manager or coordinator position was also recommended.   
 The number of paid staff at NSPs assessed varied from four to 18.  NSP managers or 
assistants (mainly nurses) were responsible for daily management of NSP operations, including 
recruitment and training of outreach workers, supply management and reporting of NSP data to 
donor organizations.  All NSP managers said they received special trainings on PWID-friendly 
services and NSP management, either funded by GFATM/UNDP or PEPFAR/USAID.  Most NSP 
manager interviewed said they did not have sufficient knowledge and skills to provide HIV care and 
treatment adherence support to HIV positive clients.  Many of them also expressed the need for 
more trainings for NSP staff and outreach workers on working with sex partners of PWID and 
couple-based counseling. 
 Each NSP had a team of three to five outreach workers. Most NSP teams, although not all, 
included both males and females of different ages and ethnic backgrounds.  All outreach workers 
either had personal experience injecting drugs or had close relatives who inject drugs.   Most clients 
contacted NSPs through outreach workers, who distributed clean needles and syringes or vouchers 
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for these supplies in the case of pharmacy-based NSPs.  Outreach workers were also responsible for 
collection of used equipment.    NSP managers preferred working with outreach workers who were 
not PWID, as based on their experiences, PWID volunteers were more difficult to monitor and 
supervise in terms of adherence with the required document completion.  Many NSP managers also 
voiced concerns about high rates of turnover among outreach workers, especially those who were 
PWID, requiring continuous training of newly recruited outreach workers.  Active injecting drug 
use, low salaries and limited transportation compensation were reported by managers and 
outreach workers as key reasons for outreach worker attrition at NSPs.  NSP sites also had one to 
two volunteers that worked primarily with outreach workers to supplement distribution and pick-
up of needles and syringes to be distributed to other PWID (secondary distribution).   
Adherence Status to Standard 3: Partially compliant.  
Standard 4: NSPs are located in at least 80% of all cities and regions where PWID are 
present and are accessible to PWID 
 The total number of NSPs operating in the country during the past several years varied 
depending on the availability of funding.  At the time of the assessment NSP located outside of 
prisons were available in three out of seven regions of the Kyrgyzstan Republic.  Most NSPs (25 out 
of 45) were concentrated in the Chui Region and Bishkek City, areas with highest prevalence of 
drug use according to the latest UNDP/GFATM-funded PWID size estimation survey conducted by 
the Center for Healthcare Policy Analysis in 2014 (CHPA, 2014).  Jalalabad Region, which is also 
known for high rates of injection drug use, with an estimated 650 PWID residing in the region  
(CHPA 2014) and is located on drug trafficking routes, at the time of the assessment had no 
functioning NSPs. During the assessment, there were also no NSPs noted in Talas, Batken and Naryn 
Regions which are believed to have very low injecting drug use prevalence, but lack clear evidence 
to support this perception.  Considering the above, the access of PWID to NSP in the Kyrgyz 
Republic was low, as only 55% of regions had at least one NSP.  
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 The minimum requirements for NSP location and working hours were described in the NSP 
Standards. Based on information from NSP managers, NSPs were not always located close to areas 
that were reported to have a high prevalence of drug use.  This was especially true for facility-based 
NSPs given that, by definition, these were located within fixed health facilities.  Nevertheless, most 
focus group participants reported NSP locations as being easily accessible.    
 Hours of operation for most facility and NGO-based NSPs were from 9 am – 6 pm on 
working days only, though some were open from 8 am - 4 pm and were opened on Saturdays.  
Pharmacy-based NSPs were open 24/7. Most PWID that participated in the focus group discussions 
found NSP hours of operation to be appropriate.  
Adherence Status got Standard 4: Partially compliant.  
Standard 5:  The program actively involves PWID in planning and delivery of NSP 
services and regularly seeks anonymous feedback from clients 
 NGOs working with PWID are regularly consulted by the GFATM Project Implementation 
Unit at UNDP and the National Coordination Committee to determine the most appropriate and 
acceptable equipment for inclusion in GFATM proposals and procurement plans. PWID are 
routinely involved in NSP implementation as outreach workers and volunteers.  
 The anonymous feedback from clients on the quality and the range of supplies provided to 
them is mainly collected through outreach workers on an ad hoc basis and is not routinely 
documented or systematically analyzed.    
Adherence Status to Standard 5: Partially compliant.  
Standard 6:  The NSP service is low-threshold and maintains confidentiality  
 NSP did not collect or record any personal information from their clients. Unique identified 
codes (UIC) consisting of the fist two letter of clients’ mother’s and father’s name, gender and the 
last two digits of year of birth were used to document PWID contacts with the program.  PWID are 
never required to provide any personal information in order to receive services. PWID can be 
refused access to services only in the case of drug use at the site or violent behavior.   
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Adherence Status to Standard 6: Fully compliant.  
Standard 7:  The service provides a range of injecting equipment that is appropriate for 
local injecting practices and substances and includes low dead space syringes/needles. 
 According to NSP managers, all NSPs assessed provided a range of needles and syringes to 
PWID. National NSP Standard of the Kyrgyz Republic requires prioritizing procurement of single-
unit low dead-space syringes. Recommendations on Universal Access of PWID to HIV prevention, 
care and treatment services approved by the Ministry of Health (order №532 from September 22, 
2014) of the Kyrgyz Republic also included a recommendation for NSP to provide different size low 
dead-space syringes with detachable needles.  The NSP included in the study had LDSS with 
attached needles (1ml single-unit insulin syringes) and detached high dead space syringes (HDSS) 
disposable needles and syringes.  LDSS with detachable needles were not available.  Based on PWID 
and NSP staff feedback, 2 ml and 5 ml syringes are the most commonly used syringe by PWID.  
Additionally, 10 ml syringes are in high demand, especially by those that use ephedrine and 
“hanka”5 as opposed to heroin.  Separate needles from 1ml insulin syringes were also in high 
demand, especially by people that have damaged or collapsed veins and need to inject into smaller 
vessels or women who are trying to have less visible injection marks.  
 According to the focus group participants and NSP managers, most clients considered the 
range of injecting equipment provided by NSPs as fully appropriate for their injecting practices. 
NSP staff and PWID who participated in the focus groups also expressed satisfaction with the range 
of supplies available at NSPs.  The only recommendation from both the clients and the NSP staff was 
to increase the number of alcohol wipes from one to three per each needle/syringe and provide 
separate small bore (“insulin”) needles.  
 In addition to needles and syringes, NSP sites provided male condoms and injecting-related 
paraphernalia, including alcohol wipes, tourniquets, single use acid sachets and naloxone.  Alcohol 
                                                             
5Home-made poppy straw preparation/extract 
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wipes were in high demand among all PWID, according to the focus group participants and NSP 
staff.  Condoms were mentioned by female PWID as an important commodity distributed by NSP.  
Naloxone is also in high demand, especially among outreach workers, who often serve as the first 
aid service for people that have overdosed.  None of the sites assessed provided female condoms, 
filters, sterile water for injections or steel spoons to their clients.  
Adherence Status to Standard 7: Partially compliant.  
Standard 8:  There are no limits on the quantity of injecting equipment provided and 
return of used injecting equipment is not a prerequisite for clients to receive new 
injecting equipment.  
 As per the national NSP Standards, there were no limits on the quantity of needles and 
syringes provided to one PWID.  However, recommendations on the optimal amount of supplies 
distributed to each PWID from the national NSP Standards described above were sometimes 
interpreted by NSP staff as upper limits and PWID were only able to receive up to two needles/ 
syringes per PWID day. The return of used injecting equipment was often a prerequisite for clients 
to receive new injecting equipment and outreach workers were expected to ensure that their 
clients return at least 50% of the distributed needles/syringes.   
Adherence Status to Standard 8: Partially compliant.  
Standard 9: The NSP services provide targeted information, education and 
communication (EIC), including prevention of HIV transmission during sex and 
overdose prevention 
 The range of EIC materials available at NSP sites was limited; many sites did not receive any 
EIC materials during the past 12 months and only had few brochures left to distribute to clients.  
Non-injecting sex partners of PWID were rarely involved in NSP activities. 
Adherence Status to Standard 9: Partially compliant.  
Standard 10: Formalized referral pathways between NSPs and other relevant service 
providers are established and NSP clients are referred to these services as appropriate 
 Only one NGO-based NSP site had formalized referral pathways (signed site-level 
Memorandums of Understandings or Referral Agreements) with local FMC to provide HIV testing 
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and TB and STI screening, testing and treatment services.  Most FMC-based NSPs did not have any 
formal arrangements for their clients to receive different health services at the facilities.  Most NSPs 
depended on informal and personal arrangements with managers or clinical staff of different health 
facilities.  The existing referrals were poorly documented (please see more details under Aim 2 
below).  
Adherence Status to Standard 10: Not compliant.  
Standard 11: The NSP program implementation includes routine monitoring, 
evaluation and quality assurance  
 UNDP as the prime recipient of the GFATM-HIV grant was responsible for NSP monitoring 
using the list of project-specific indicators approved as part of the country HIV proposal to the 
GFATM and described in the project M&E Plan.  All NSPs were monitored on quarterly basis by staff 
from the GFATM Project Implementation Unit (PIU) at UNDP using the GFATM-supported 
Management Information System (MIS) data and during scheduled site-monitoring visits. Upon the 
request from the GFATM, the Local Fund Agent – an organization that is contracted by the Global 
Fund to assess arrangements for implementation, and endorse requests for disbursements, also 
conducts annual on-site verification visits to check the accuracy of data reported to the GFATM.  
Implementation of the facility-based NSPs was additionally monitored by the Republican Narcology 
Center (RNC) as the sub-recipient of the GFATM grant.  On a monthly basis, M&E specialists from 
the RNC reviewed data entered by staff of facility-based NSPs into the MIS and conducted quarterly 
on-site monitoring visits.  
 According to all stakeholders interviewed, M&E of NSP in the Kyrgyz Republic was one of 
the biggest weaknesses of the program. At the time of the assessment, a national comprehensive 
monitoring and evaluation plan to track coverage and outcomes of NSP service delivery was not 
available.  National NSP coverage (number of PWID reached by HIV prevention activities), outcome 
(use of clean needles and syringes) and impact (HIV prevalence) were included in the National Plan 
to Monitor Implementation of the National HIV/AIDS Program from 2012-2016.  Collection of data 
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on those indicators was done during the biannual integrated bio-behavioral surveillance surveys 
(IBBS) among PWID. In addition, the National Plan specifies that data collected using the MIS 
managed by GFATM could be used to verify indicators collected through the IBBS.   
 Based on the feedback received from the NSP staff and key stakeholders, the accuracy of 
information entered into the MIS from the standard client contact registration forms developed by 
GFATM and distributed to all NSP completed by the outreach workers was difficult to verify and 
required improvement.  Unique identified code (UIC) that is assigned to each client and recorded 
into the MIS to track the client's interaction with the program can easily be changed by clients 
themselves or falsified by outreach workers to increase the reported number of clients served.  The 
MIS does not allow tracking of duplicate clients that receive similar services in different NSPs.  
 Limited information exchange and data sharing between the Government structures 
mandated to coordinate HIV prevention activities among PWID, namely the Republican Narcology 
Center and the Republican AIDS Center and the NGOs working with PWID, was of concern to key 
stakeholders and was considered an obstacle to increasing effectiveness of NSP implementation 
and country ownership of the program.  
Adherence Status to Standard 11: Partially compliant.  
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Table 7.  Compliance of NSP implementation in the Kyrgyz Republic with the WHO, UNODC, 
UNAIDS recommendations on quality standards at the service level  
(4 – fully compliant; 2– partially compliant; 0– does not comply with the recommendations).    
Recommendation Status Comment 
Long-term funding has been 
secured to ensure 
sustainability 
0 As described above, NSP funding is primarily 
dependent on external aid through the GFATM-
funded HIV project that is approved up to 2018.  
The program employs a range 
of NSP service delivery 
models to maximize reach 
2 As described above, there were facility-based NSPs 
health, community-level NSP sites run by local 
NGOs, NSP sites located in penitentiary facilities and 
NSP sites managed by an NGO, but located in local 
pharmacies.  NSPs located in FMC and NGOs also 
provided outreach services. No mobile services or 
automated vending machines dispensing injecting 
equipment.  
The NSP workforce has 
received appropriate training 
and is supervised 
4 NSP staff, including outreach workers are routinely 
trained in different topics.  
NSPs are located in at least 
80% of all cities and regions 
where PWID are present and 
are accessible to PWID 
2 As described above, NSPs were not always located 
close to areas that were reported to have a high 
prevalence of drug use, however most PWID 
considered them as accessible. 
The program actively 
involves PWID in planning 
and delivery of NSP services 
and regularly seeks 
anonymous feedback from 
clients 
2 NGOs working with PWID are regularly to 
determine the most appropriate and acceptable 
equipment for inclusion in procurement plans. 
PWID are routinely involved in NSP implementation 
as outreach workers and volunteers.  
The anonymous feedback from clients on the 
quality and the range of supplies provided to them 
is not routinely collected or systematically 
analyzed.    
The NSP service is low-
threshold and maintains 
confidentiality 
4 NSP did not collect or record any personal 
information from their clients. PWID are not 
required to provide any personal information in 
order to receive services. PWID can be refused 
access to services only in the case of drug use at the 
site or violent behavior.   
The service provides a range 
of injecting equipment that is 
appropriate for local injecting 
practices and substances and 
2 NSPs provided a range of syringes/needles, 
including LDSS with attached needles (1ml single-
unit insulin syringes) and high dead space syringes 
(HDSS) disposable syringes (2ml, 5m and 10ml) 
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Recommendation Status Comment 
includes low dead space 
syringes/needles. 
with detachable needles, male condoms, alcohol 
wipes and naloxone. Few provided tourniquets.  
Most clients considered the range of injecting 
equipment provided by NSPs as fully appropriate 
for their injecting practices. NSP included in the 
study had LDSS with detachable needles were not 
available. NSP had no female condoms, filters, 
sterile water for injections or steel spoons to their 
clients.   
There are no limits on the 
quantity of injecting 
equipment provided and 
return of used injecting 
equipment is not a 
prerequisite for clients to 
receive new injecting 
equipment 
2 Recommendations on the optimal amount of 
supplies distributed to each PWID from the national 
NSP Standards were sometimes interpreted by NSP 
staff as upper limits and PWID were only able to 
receive up to two needles/ syringes per PWID day. 
The return of used injecting equipment was often a 
prerequisite for clients to receive new injecting 
equipment and outreach workers were expected to 
ensure that their clients return at least 50% of the 
distributed needles/syringes.   
The NSP services provide 
targeted information, 
education and 
communication, including 
prevention of HIV 
transmission during sex and 
overdose prevention  
2 The range of EIC materials available at NSP sites 
was limited; many sites did not receive any EIC 
materials during the past 12 months and only had 
few brochures left to distribute to clients.  Non-
injecting sex partners of PWID were rarely involved 
in NSP activities. 
Formalized referral pathways 
between NSPs and other 
relevant service providers are 
established and NSP clients 
are referred to these services 
as appropriate  
0 Most NSPs depended on informal and personal 
arrangements with managers or clinical staff of 
different health facilities.  Referrals were poorly 
documented.    
The NSP program 
implementation includes 
routine monitoring, 
evaluation and quality 
assurance 
2 Routine monitoring is implemented by UNDP. No 
National M&E  for NSP implementation.  
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Aim 2: Compare effectiveness of three NSP service delivery modalities (NGO-based, 
government medical facility based and pharmacy based) in the Kyrgyz Republic  
 Success of the three NSP delivery modalities (NGO-based, medical facility-based and 
pharmacy-based) in reaching specific short-term outcomes was compared during this study using 
the existing data routinely collected and stored in the GFATM-managed MIS database (see table 8 
for a short summary). The short-term outcomes compared across modalities were as follows: 
1. reaching, engaging and providing PWID with the means to reduce HIV risks related to 
injecting and sexual behaviors; 
2. ensuring regular HIV testing and counseling of PWID;  
3. linking and referring PWID to OST programs, TB screening and treatment, and 
antiretroviral therapy (ART) programs. 
Reaching, engaging and providing reached PWID with the means to reduce HIV risk related to 
injecting and sexual behaviors. 
 According to the NSP managers and participants of the focus group discussions conducted 
with PWID, provision of clean needles and syringes is the most useful service that NSPs, across all 
three modalities, although most PWID often purchase their syringes at local pharmacies.  PWID 
population size estimates were not available for individual sites in the Kyrgyz Republic, therefore 
this assessment was not able to collect necessary data and draw any definitive conclusions about 
the coverage of PWID in a particular geographical area by a particular type of NSP. Overall, the 
coverage level equal to 45% of the estimated population of PWID reported by UNDP during the first 
six months of 2015 on its own was not sufficient to achieve significant decrease in HIV infections.  
Number of needles/syringes distributed per PWID in the last 12 months. 
 According to the international guidelines this indicator should be measured as the number 
of needles and syringes distributed per PWID out of the total estimated number of PWID in the 
catchment area.  PWID population size estimation data was not available for the catchment areas of 
different NSP types or individual NSPs, therefore this indicator was measured as the number of 
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syringes/needles distributed per one client.  According to UNDP data all NSPs distributed 5,021,630 
clean needles and syringes to the estimated 25,500 PWID during 2014, which provides an average 
of 201 syringes per PWID per year. 
The total number of needles/syringes distributed by different NSPs included in this study 
during 12 months (from January 1, 2014 to December 31, 2014) ranged from 85 to 581, with a 
median of 214 needles/syringes per PWID per 12 months for all the sites assessed (interquartile 
range (IQR): 100-437).  On average, NGO-based NSPs distributed 285 (IQR: 214-320) 
needles/syringes, facility-based NSPs distributed the maximum, namely 472 (IQR: 427-578) 
needles/syringes, and pharmacy-based NGOs distributed the least, namely 102 (IQR: 91-103) 
needles/syringes (Figure 1).  There was a statistically significant difference between groups in the 
mean number of needles and syringes distributed per PWID during 12 months (p = 0.001). The 
mean number of needles and syringes distributed during 12 months was statistically significantly 
higher among the NSPs located in government health facilities compared both to NSPs run by NGOs 
(186.4 ± 45.3, p = 0.002) and NSPs operated through pharmacies (370.1 ± 40.4, p =0.000). 
Figure 1. Mean number of needles/syringes and IQR (all and low dead space syringes 
(LDSS)) distributed per PWID during January 1, 2014 to December 31, 2014, by type of NSP 
 
 
  
 
 The number of low dead space syringes distributed to PWID was statistically significantly 
lower (p = 0.000) than the number of high dead space syringes distributed to PWID at all NSP 
modalities during the 12 months with no statistical differences between the modalities (p=0.08).  
Both participants of the FGDs and NSP staff reported that often NSP clients collect syringes 
for other people that inject drugs, and that NSPs rarely collect information and document final 
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recipients of needles and syringes that they provided to secondary exchangers, a term used to 
describe PWID who collect clean injecting equipment from NSPs and redistribute them to other 
PWID, sometimes at a cost, also known as “role holders”.   
Number of condoms distributed per PWID in the last 12 months. 
 The total number of condoms distributed per PWID by different NSPs during January 1, 
2014 to December 31, 2014 ranged from 7 to 95, with the average of 52 condoms per PWID per 
year for all sites assessed (IQR: 44-71).  On average, NGO-based NSPs distributed 58 condoms (IQR: 
44-72), facility-based NSP distributed 55 condoms (IQR: 52-68) and pharmacy-based NGOs 
distributed 7 condoms per one PWID reached.  There was no significant difference (p=0.08) in the 
number of condoms distributed to each PWID reached by NGO and facility-based NSPs.  Pharmacy-
based NSPs distributed significantly less condoms (p=0.002) (Figure 2).  
Figure 2. Mean number of condoms and IQR distributed per PWID during January 1, 2014 to 
December 31, 2014, by type of NSP. 
Number of PWID who were reached by an NSP at least once in the past 12 and six 
months. 
 It is estimated that there are 25,000 PWID in the Kyrgyz Republic (CHPA, 2014). According 
to the UNDP/GFATM progress report 11,405 PWID were reached at least once by NSP programs 
during the first six months of 2015, which represented 45% of the estimated number of PWID in 
the country.  
 During the 12 months of 2014 the assessed sites had from 145 to 2689 clients, with a 
median of 605 clients (IQR: 274-809).  There was no statistically significant difference between the 
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mean number clients by NSP modality (p=0.2).  During the first six months of 2015, the assessed 
sites had from 111 to 2019 clients, with a median of 477 clients (IQR: 304-695).  There was no 
statistically significant difference between the mean number clients by NSP modality (p=0.192) 
(Figure 3).  Males constituted 87% of all the clients and there was no statistically significant 
difference between the mean number of clients among male and female clients by NSP modality 
(p=0.447).  Pharmacy-based NSP were reaching younger PWID compared to NGO and facility-based 
NSPs (p=0.000).  Thus, people younger than were less than 25 years of age represented on average 
50% (95%CI:42-57%) of all clients reached by pharmacy based NSP during 2014.  The proportion 
of young PWID among clients of NGO and facility-based NSPs was 6% (95%CI: 3-9%) and 3% 
(95%CI: 0.1-6%) accordingly.      
Figure 3. Mean number of PWID reached by an NSP at least once during January 1, 2014 – 
December 31, 2014 (in dark blue) and January 1, 2015 – June 30, 2015 (in light blue), by NSP 
type, with IQR. 
 
Percentage of PWID who were regularly (at least once per month) reached by an NSP 
over a six month period 
 The percentage of NSP clients who accessed an NSP on a regular basis (at least once per 
month during January 1, 2015 – June 30, 2015) out of those who used NSP services at least once 
during the same six months, ranged from 19% to 99%.  On average, the percentage of regular 
clients was statistically higher among clients of facility-based NSPs compared to NGO-based NSPs 
(p=0.045) and pharmacy-based NSPs (p=0.007). Thus, regular clients comprised 56% (95%CI: 34-
78%) of clients reached through NGO-based NSPs, 80% (95%CI: 69-91%) of clients reached 
through facility-based NSPs, and 19% of clients reached by pharmacy-based NSPs (Figure 4).  There 
was no statistically significant difference between the proportion of regular clients among male and 
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female clients by NSP modality.  A linear regression analysis did not establish any statistically 
significantly relationship between the overall number of clients served by an NSP site of any 
modality during the past six months and the regularity of contacts.    
Figure 4. Percentage of NSP clients who were regularly reached by NSP over January 1, 2015 
– June 30, 2015, by NSP type, with 95%CI.  
 
Ensuring regular HIV testing and counseling of PWID.  
 Only a few of the NGO-based NSP sites (three out of 12 NSP sites) included in the 
assessment were offering HIV testing and counseling using HIV rapid tests, including one that used 
oral fluid-based testing. Two sites were providing HIV counseling services and collected blood that 
was then sent for HIV testing to the local AIDS Center.  All sites reported referring patients for HIV 
testing to local health facilities and/or CDC-supported mobile HIV counseling and testing points 
(vans equipped with HIV rapid tests). 
Percentage of eligible NSP clients tested by NSP on-site for HIV during the last six 
months. 
As mentioned above, on-site HIV testing was reported by three NGO-based NSPs.  In these 
three sites, only 7% of clients who received services during the past six months were reported as 
being tested for HIV using rapid HIV test kits. 
Percentage of NSP clients referred by NSP for HIV testing and counseling (HTC) during 
the last six months. 
All sites reported referring their clients for HTC.   The proportion of clients referred for HTC 
as reported in the MIS during January 1, 2015 to June 30, 2015 ranged from 5-70%. NGO-based 
NSPs reported that 15% (95%CI: 2-28%) of clients reached during January 1, 2015 to June 30, 2015 
were referred for HTC, while at facility-based NSPs this indicator was for 34% (95%CI: 7-60%) of 
clients and 40% at pharmacy-based NSPs.  There was no statistically significant difference between 
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the percentages of NSP clients referred for HTC by different NSP types as reported through the MIS, 
the NSP program monitoring database managed by GFATM (p=0.3).   
Linking and referring of reached PWID to other health services  
 According to the WHO, UNODC, UNAIDS recommendations, NSPs should aim to facilitate 
access of PWID to HIV testing, HIV treatment, care and support services and to other health and 
welfare services.  
Percentage of NSP clients referred by NSP to Opioid Substitution Therapy (OST) services 
during the last six months 
During individual interviews, almost all NSP managers rated poorly their own referrals of 
PWID to OST.   According to the program data review, only six out of the 12 sites assessed reported 
referring clients to OST.  Out of the total number of NSP clients reached by NSPs during the first six 
months of 2015, less than 2% were referred to OST programs.  The referral rates did not 
statistically differ by NSP types (p=0.8).  The unfavorable reputation of OST among PWID and 
absence of sufficient trainings on OST for NSP staff were cited as key barriers to more effective 
referrals of NSP clients to OST.  
Percentage of NSP clients referred by NSP to STI services during the last six months 
None of the sites reported screening clients for STI symptoms on-site. Out of 7,249 clients 
reached by NSPs included in the assessment, 698 (13%) were referred for STI screening and testing 
(Figure 5).  Pharmacy-based NSPs were referring more patients to STI services than NGO-based 
NSPs (28% ± 8.8%, p = 0.03).  The differences between facility-based NSPs and NGO-based NSPs 
and facility-based NSPs and pharmacy-based NSPs was not statistically significant (p=0.5 and 
p=0.07 respectively).  
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Figure 5. Percentage of NSP clients referred by NSP to STI services during January 1, 2015 to 
June 30, 2015 
 
Percentage of HIV-positive NSP clients enrolled in HIV care 
There was no information on the percentage of HIV-positive NSP clients referred to or 
enrolled in HIV care in the NSP program database.  This information is not routinely collected or 
recorded by sites.   Many NSP staff reported not feeling empowered or trained enough to counsel 
HIV-positive clients.  
Table 8.  Comparison of effectiveness of three NSP service delivery modalities (NGO-based, 
government medical facility based and pharmacy based), by select indicators 
Indicator Study results Comment 
Reaching, engaging and providing reached PWID with the means to reduce HIV risk 
related to injecting and sexual behaviors. 
Average number of 
needles/syringes distributed 
per PWID in the last 12 
months  
NGO-based: 285 (IQR: 214-320) 
Facility-based: 472 (IQR: 427-578) 
Pharmacy-based: 102  
Facility-based NSPs 
distributed significantly 
higher number of 
syringes per PWID per 
year.  
Number of condoms 
distributed per PWID in the 
last 12 months. 
NGO-based: 58 (IQR: 44-72) 
Facility-based: 55 (IQR: 52-68) 
Pharmacy-based: 7 
Pharmacy-based NSPs 
distributed the lowest 
number of condoms per 
PWID per year. 
Number of PWID who were 
reached by an NSP at least 
once in the past six months 
NGO-based: 910 (IQR: 472-945) 
Facility-based: 350 (IQR: 216-483) 
Pharmacy-based: 600 
No statistically 
significant difference 
between the mean 
number clients by NSP 
modality.  
Percentage of PWID who 
were regularly (at least once 
per month) reached by an 
NGO-based: 56% (95%CI: 34-78%) 
Facility-based: 80% (95%CI: 69-
The percentage of 
regular clients was 
statistically higher 
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Indicator Study results Comment 
NSP over a six month period 91%) 
Pharmacy-based: 19% 
among clients of facility-
based NSPs. 
Ensuring regular HIV testing and counseling of PWID.  
Percentage of eligible NSP 
clients tested by NSP on-site 
for HIV during the last six 
months. 
NGO-based: 7% (95%CI: 0-17%) 
Facility-based: 0% 
Pharmacy-based: 0% 
Rapid HIV tests were 
available at three NGO-
based NSPs only. 
Percentage of NSP clients 
referred by NSP for HIV 
testing and counseling (HTC) 
during the last six months 
NGO-based: 15% (95%CI: 2-28%) 
Facility-based: 34% (95%CI: 7-
60%) 
Pharmacy-based: 40% 
No statistically 
significant difference 
between the 
percentages of NSP 
clients referred for HTC 
by different NSP types. 
Linking and referring of reached PWID to other health services  
Percentage of NSP clients 
referred by NSP to Opioid 
Substitution Therapy (OST) 
services during the last six 
months 
NGO-based: 2% (95%CI: 0-7%) 
Facility-based: 0.4% (95%CI: 0-
0.8%) 
Pharmacy-based: 0% 
No statistically 
significant difference 
between NGO and 
facility-based NSPs.  
Pharmacy-based NSP 
were not referring 
patients to OST. 
Percentage of NSP clients 
referred by NSP to STI 
services during the last six 
months 
NGO-based: 6% (95%CI: 0-14%) 
Facility-based: 12% (95%CI: 4-
19%) 
Pharmacy-based: 34% 
Pharmacy-based NSPs 
were referring more 
patients for STI 
screening and 
treatment. 
Percentage of HIV-positive 
NSP clients enrolled in HIV 
care 
 
NGO-based: 0 
Facility-based: 0 
Pharmacy-based: 0 
There was no 
information on the 
percentage of HIV-
positive NSP clients 
referred to HIV care  
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Aim 3. Identify obstacles and facilitators that affect PWID’s uptake and coverage of NSP 
services for each modality of NSP delivery 
 Barriers and facilitators that affect PWID uptake of NSP services were identified based on 
the information received during the focus group discussions with PWID. 
Key barriers that affect uptake of NSP services by PWID 
Fear of police  
 According to PWID and NSP staff, fear of police pursuits is the key factor that prevents 
PWID from accessing NSP services as seen in this comment:  
“…we are afraid of the police. They can follow us around the NSP and detain us…”- female, 
Bishkek 
 Many participants in the FGDs voiced that they think police follow people that enter NSP 
sites.  A significant proportion of PWID that participated in the FGDs said they have either 
experienced themselves or heard about policemen detaining NSP clients in the immediate 
proximity around the NSP sites.   Several NSP staff mentioned that they often get complaints from 
the clients about police, and that clients do not want to come to the NSP because they are afraid to 
be seen at the NSP and detained by the police.  According to the FGD participants, storing and 
carrying used syringes to exchange them for clean syringes made PWID more vulnerable to arrests. 
According to them, police could test washouts from used syringes for traces of drugs and arrest 
them on the grounds of drug possession.  A number of FGD participants also claimed that they were 
arrested by the police only on the basis of the injection marks on their body parts.  
Limited geographic presence 
 Limited geographical presence of NSP sites and lack of funds to cover transportation costs 
also prevents PWID from using services.  Outreach workers work in established catchment areas 
and usually only serve a group of clients that reside close to their own place of residence.  
Considering that the overall number of outreach workers is small, they are unable to capture all 
PWID that reside in the administrative district that is assigned to a certain NSP.     
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Stigma around drug use 
 The phrases “lack of trust” and “fear to be known as a drug user” were used frequently 
when describing obstacles for PWID uptake of NSP services.  According to the FGD participants, 
PWID do not trust people around them, including other PWID:  
“…they [PWID] have had a lot of [bad] experiences. They don't trust anyone, and its not just 
about pharmacies, they [PWID] don't even trust each other.” – male, Bishkek 
 In the Kyrgyz Republic, there is a procedure to officially register people with drug 
dependence (narcological register). People are entered in the registry by a substance use specialist 
upon diagnosing mental and/or behavioral disorders related to drug use. According to the 
information received during focus groups and interviews with NSP managers, registration with 
narcology services often leads to registration in the police register, which may have negative 
consequences, such as withdrawal of the patient’s driving license. This discourages many PWID 
from using NSPs.  PWID fear that if they are seen at the NSP site or use NSP services or frequently 
buy syringes at the same pharmacy, their information will be disclosed to police or others 
(employer, parents, spouses, relatives).  In addition to potential police pursuits, the fear of 
becoming known as a person who injects drugs was likely related to high social stigma related to 
drug use.   
“I know it myself, for the first five years [of injecting] I didn’t even consider that I was a drug 
addict. That wasn't in my head. I was always telling that this is nonsense, I can always 
stop.”- male, Osh. 
 Focus group participants stated that if someone finds out about their drug injecting habits, 
they could be fired from their workplace, blamed by their family and neighbors, and treated poorly 
by medical personnel when seeking health services.  Related to the stigma around drug use, some 
respondents said that the younger and less experienced people who use drugs deny the fact that 
they are addicted to drugs and, therefore, do not want to associate themselves with NSP, as these 
are considered a last resort for those injecting drugs.   
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“They [young PWID] are afraid to be exposed, if one of their relatives or friends will find out 
[about injecting], they will start talking.” - staff of an organization that works with PWID. 
 When asked about the obstacles related specifically to females that use drugs, many focus 
group participants mentioned “shame” or “embarrassment”.  Women who inject drugs, according to 
the focus group participants, experience much higher rates of social stigma, even from their 
injecting male spouses.  This is the reason why many women prefer to inject alone or with their 
male sexual partner, but avoid going to NSPs or using outreach services in order not to disclose 
their injecting status.  
“First of all, they [female PWID] are afraid of publicity. No one knew, no one had seen. For 
women it is easier to do it [inject drugs] quietly, secretly, so that no one would even 
suspect”- female, Sokuluk 
“We [women] are treated differently.  We are wives, mothers, homemakers. And imagine 
they learn that I am a drug addict. So I am forced to hide everything.”- female, Bishkek 
 Participants of focus group discussions also mentioned that they sometimes experience an 
unfriendly attitude from NSP staff and do not prefer to use the services.   Because NSP staff do not 
include people who have individual experience using drugs, PWID do not trust them and fear that 
their information might be shared with police.   
“.. sometimes they [NSP staff] are not nice, and treat us with contempt.  Just get you syringes 
and get lost” – female, Bishkek 
Lack of motivation 
 Lack of motivation and “laziness” of PWID are also factors for the low uptake of NSP 
services.  Since fixed NSPs are only available in select locations, PWID are not willing or do not have 
extra money and time to travel to the sites to pick up clean needles and syringes.  Several PWID said 
that if they have money to buy heroin, they will most likely find three soms to buy a clean 
needle/syringe at a local pharmacy, which are available “on almost every corner” and are open 
24/7.  
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Lack of information 
 Lack of information about NSP was mentioned by NSP staff and PWID as another potential 
barrier for more PWID using NSP services.  PWID, especially those that are younger, those with less 
experience, and those who only communicate with a small network of people, have no information 
about availability of NSP services and therefore do not use them.    
Key facilitators that could improve uptake of NSP services by PWID 
Free distribution of wide range of supplies  
 Although, many PWID noted that syringes are available for purchase at all local pharmacies 
and most PWID are able to afford buying them, free distribution of clean injecting equipment 
remains to be an important factor attracting PWID to NSP services, especially long-time injectors 
and PWID that have no employment and no family support. 
“A syringe they can purchase. It is available and inexpensive.  Every drug addict will find 
three or five soms to buy himself a syringe” – male, Osh 
“...and when everything ends, there is no longer a father, a mother, no money, no car, no 
apartment ... then he [PWID] enters the program. Because there is nowhere else to go. No 
money to buy syringes .... Because of despair” – male, Bishkek 
 Availability of a wide range of injecting equipment, including different size of needles and 
syringes, cotton, water for injections and alcohol swabs provided in unlimited quantities would 
facilitate increased use of NSP services.  Availability of other supplies, including naloxone and 
wound care supplies (antibacterial solutions and ointments, dressings), could, in the opinion of 
focus group participants, also make NSP services more attractive to PWID.   
Availability of outreach   
 Availability of wide-network outreach services was considered as another key factor that 
could facilitate regular use of NSP services by PWID.   Many focus group participants said that they 
prefer getting clean syringes and needles from an outreach worker, as it is more convenient for 
them than traveling to an NSP site.  NSP staff also confirmed that they primarily work with clients 
through outreach. PWID had different opinions about the ways outreach services were provided to 
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them: some preferred when an outreach worker brought clean needles and syringes to their home, 
some were afraid that their relatives or neighbors would see an outreach worker carrying syringes 
and, therefore, preferred to meet with an outreach worker somewhere else.  A few PWID said it is 
easier for them to come to an NSP themselves, especially if the working hours of an NSP site are 
extended until at least 3 pm, rather than wait for an outreach worker.   Most PWID agreed that the 
combination of different service provision modalities – through outreach workers, at fixed NSP 
sites, using mobile NSP and through pharmacies - would cover the needs of most PWID. 
Other free-of-charge services 
 FGD participants and NSP staff also suggested that PWID would use NSP services more if the 
programs would provide additional free-of-charge services (preferably provided on-site), 
specifically dental services, wound care services, HBV and HCV testing and social and legal support 
services.  
Better information 
 Also, a number of focus group participants and NSP staff said that NSPs would attract more 
PWID if fixed NSP sites would periodically organize group informational sessions, distribute quality 
information materials, show short educational films, provide tea and light snacks and allow PWID 
to socialize (see comment).  In every focus group discussion, at least one person cited that PWID 
lack a safe place to receive information and communicate with each other, and NSPs could provide 
this opportunity. 
“Now there are no problems with syringes, but we need more information. It is important to 
inform youth about consequences. And [also important for] people to have a chance to talk 
to each other” – male, Osh 
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CHAPTER V. DISCUSSSION 
Aim 1. Describe the existing NSP in the Kyrgyz Republic and assess the extent to which it 
adheres to international standards.  
 The assessment showed that implementation of the NSP in the Kyrgyz Republic was 
supported by the national legislation.  The existing NSP-related regulations were mostly in line with 
the international standards for NSP policy and legislation, although certain recommended program 
components were overlooked.  Specifically, the existing NSP Standards did not include any 
provisions about mechanisms whereby clients can confidentially /anonymously provide feedback 
on the service.  Also, the existing policies did not include any systems or specific plans to prevent 
NSP commodity stock-outs.  Some of the international recommendations were only partially 
reflected in the national policy and legislation.  For example, the mentioned above Order on HIV 
Prevention in the State Bodies of Internal Affairs, Drug Control and Penitentiary System that 
endorsed NSP implementation in penitentiaries did not explicitly stipulate that police activities do 
not deter or prevent PWID from accessing NSPs or from being in possession of new or used 
injecting equipment.   
The quality of the NSP implementation was also only partially aligned with the existing 
international recommendations.   Thus, the funding for the NSP program was only sufficient to 
cover basic NSP services and was primarily dependent on external aid, although there were some 
indications that the Government of the Kyrgyz Republic might consider funding the program using 
internal resources.  Until the decision to allocate sufficient national resources to NSP 
implementation is finalized, the sustainability of the program is questionable considering the 
complete reliance on external donor funding. Geographical availability of NSP services was low.  
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The country did not have a comprehensive monitoring and evaluation plan and effective tools that 
would allow systematically tracking NSP performance indicators and assess its effectiveness.   
NSPs in the Kyrgyz Republic were mainly located in urban and semi-urban areas, 
predominantly within Bishkek metropolitan area, limiting the ability of PWID that reside outside of 
larger Bishkek metropolitan area to access NSP services. Due to limited geographical availability of 
NSPs, especially in more rural areas at a district level, not all PWID had access to sterile injecting 
equipment through the established NSPs.  It is likely that access was even more limited during 
winter due to difficult road conditions (S. T. Allen, Ruiz, Roess, & Jones, 2015).  Similar to the 
findings from a number of UK-based studies (Cattan et al., 2009), this study found that many PWID 
prefer buying equipment from pharmacies or other PWID rather than obtaining it from fixed site 
NSPs and such factors as the immediate availability of a syringe, even if it was previously used by 
someone else, when drugs are available, could play a more important role than the availability of an 
NSP.  
 At the time of the assessment, the NSP in the Kyrgyz Republic utilized a range of service 
delivery modalities, but the majority of NSP contacts in the Kyrgyz Republic was through outreach 
workers, which is similar to other NSPs around the world (Hebert et al., 2008). Females constituted 
13% of all NSP clients, which corresponds to the estimated proportion of female PWID (12%) and is 
slightly higher than the proportion of females among officially diagnosed patients with opioid 
dependence (7%) in the Kyrgyz Republic (CHPA, 2014). Aside from pharmacy-based distribution of 
syringes, no other service delivery models, like syringe distribution through vending machines or 
mobile exchange points, existed that were tailored to specific needs of young PWID or women 
(Conner, 2015; Frank et al., 2015; WHO, 2015)(Jones et al., 2010; Kermode et al., 2012; McDonald, 
2009; Obadia et al., 1999).   
All NSP modalities included in this assessment provided a wide range of syringes, but 
distributed significantly lower quantities of low dead-space syringes compared to high dead-space 
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syringes.  Lower demand of 1ml insulin LDDS syringes with fixed needles among PWID was mainly 
explained be the fact that PWID participated in the assessment preferred to get larger volume 
syringes with detachable needles, which is consistent with findings from other similar studies 
conducted in Tajikistan (Zule et al., 2015) and Lithuania (Gyarmathy et al., 2010) and corresponds 
with the fact that a significant portion of PWID in the Kyrgyz Republic use ephedrine and home-
made drug preparations as opposed to just heroin (RAC, 2014).  Also, there was no information that 
was systematically provided to PWID or NSP staff, especially outreach workers, to educate them 
about LDSS preventive advantages over conventional syringes to reduce the risk of HIV associated 
with sharing syringes.  Experience from other countries with high rates of HIV among PWID, like 
Vietnam, show that high coverage of PWID with social marketing interventions that promote the 
benefits of LDSS use to PWID and availability of larger volume LDSS play an important role to 
increasing access to and the use of LDSS for PWID (Huong et al., 2015). 
Similar to results from other countries, including Russia and Tajikistan (Panda & Sharma, 
2006; Sarang, Rhodes, & Platt, 2008), many PWID included in this assessment relied on purchasing 
clean syringes from the widely available network of commercial pharmacies. And, unlike in other 
regions of the world, for example countries of Southeast Asia and Australia (Lenton, Bevan, & 
Lamond, 2006; Panda & Sharma, 2006), the market price for clean syringes in the Kyrgyz Republic 
was considered affordable for most PWID.   
 NSP services in the Kyrgyz Republic were “low-threshold” and did not require PWID to 
meet any specific criteria in order to receive injecting equipment. The return of used injecting 
equipment was often a prerequisite for clients to receive new injecting equipment and outreach 
workers were expected to ensure that their clients return at least 50% of the distributed 
needles/syringes.  Although flexible, this exchange requirement was considered an obstacle by 
some PWID who were reluctant to carry used syringes, and expectedly led to decreased NSP 
coverage (Small, Glickman, Rigter, & Walter, 2010).  
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 PWID, especially those with unsafe injecting practices, also engage in risky sexual practices 
magnifying the risk of HIV infection (Broz et al., 2014; Chikovani, Goguadze, Bozicevic, Rukhadze, & 
Gotsadze, 2013; Mazhnaya et al., 2014; Strathdee & Sherman, 2003; Suohu et al., 2012).  Current 
models of NSP implementations in the Kyrgyz Republic focus primarily on providing PWID with 
condoms to protect themselves and their partners from sexual exposure to HIV.  Non-injecting sex 
partners of PWID were rarely involved in NSP activities.  Further linkage to HIV services and 
referrals for STI services are limited at NSP.  
Aim 2.  Compare different models of NSP service delivery currently in use 
Reaching, engaging and providing reached PWID with the means to reduce injecting risks and 
HIV infection.  
The assessment identified the following differences in program implementation outputs 
between three NSP types: the percentage of regular clients who used NSP services at least once per 
month over the six months and the mean number of needles and syringes distributed per PWID 
during 12 months.  Thus, regular clients comprised 56% of clients reached through NGO-based 
NSPs, 80% of clients reached through facility-based NSPs, and 19% of clients reached by pharmacy-
based programs.  As discussed in the Literature review, earlier research had mixed conclusions 
about the relations between the regularity of NSP contacts and needle sharing behavior, therefore it 
is hard to conclude whether the observed difference in the regularity of contacts between three NSP 
modalities could have had any influence on their overall effectiveness to decrease HIV incidence.  
 NSPs located at governmental medical facilities on average distributed the most syringes 
per client per year (472), while pharmacy-based NSPs distributed the least (102).  Both facility-
based and NGO-based NSPs on average distributed more than 200 syringes per client per year 
which could be considered as sufficient to potentially have an impact on HIV transmission among 
PWID using NSP services.  However, high number of syringes distributed per each PWID could be 
explained by a wide-spread practice of “secondary exchange” that could broadly be defined (Lenton 
60 
et al., 2006) as PWID acquiring clean injecting equipment from NSPs, and redistributing them to 
other PWID by selling them, trading them, or giving them away.  All NSP types distributed lower 
than 100 condoms per PWID per year, which is considered as ‘medium’ according to WHO 
Technical Guidelines (WHO, 2014a) .  
Ensuring regular HIV testing and counseling of PWID 
On-site HIV rapid testing was available at NGO-based NSPs, but the coverage of clients 
tested for HIV at the NSP was 7%.  Approximately 30% of NSP clients were recorded as being 
referred for HTC and this assessment revealed no statistically significant difference between the 
percentage of NSP clients referred for HTC by different NSP types.   
Despite low rates of documented on-site HTC and referrals, results of the national IBBS 
surveys and the survey among NSP clients, show that most PWID (approximately 90%), including 
NSP clients are reporting having been tested for HIV (Deryabina, 2016; RAC, 2014).  Considering 
the high number of clients using NSP services through outreach, high rates of HIV testing among 
NSP clients in the Kyrgyz Republic could indicate that NSP outreach workers were effective in 
increasing the rates of HTC testing among their clients but failed to properly document and track 
HTC referrals.  If true, this finding would have been consistent with the results of a study from Iran 
that showed the effectiveness of outreach NSP model in increasing the rates of HIV testing among 
PWID (Nazari et al., 2016).   This makes the availability of and ease of access to outreach workers all 
the more important for PWID as this was found to be a limitation in this study. All assessment 
participants considered the implementation of mobile “trust points” equipped with HIV rapid tests 
as an effective way to attract PWID to HTC and NSPs.  
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Linking and referring reached PWID to other services.  
NSPs included in the study did not sufficiently facilitate the uptake of other services by 
PWID, including access to HIV care and treatment. Pharmacy-based NSPs were referring more 
patients for STI screening and treatment, which could be because their clients were generally 
younger and sexually more active.  The assessment was not able to determine any statistically 
significant differences between different modes of NSP delivery in linking and referring PWID to 
HIV care and treatment services.  Also, none of NSP modalities included in the study were effective 
in facilitating entry into drug dependence treatment, in particular OST.  Pharmacy-based NSPs 
reported no referrals to OST; pharmacists participating in the NSP program were not trained or 
encouraged to motivate and refer clients for OST. 
Although, the results of this study showed that facility-based NSPs were more effective in 
engaging and providing reached PWID with the means to reduce injecting risks and HIV infection, 
NSPs included in this study were serving different PWID in different locations and therefore cannot 
be really compared.  Pharmacy-based NSPs were used by younger PWID.  Overall, none of the NSPs 
were effective in providing and properly documenting HIV counseling and testing services to PWID 
and their sex partners.  Also, all NSPs were ineffective in linking and referring PWID to STI, OST and 
ART services and there were no differences between different modes of NSP delivery.  
Aim 3. Identify obstacles and facilitators that affect PWID’s uptake and coverage of NSP 
services for each modality of NSP delivery. 
 Assessment revealed several layers of obstacles that negatively impact PWID uptake of NSP 
services, including social, institutional and interpersonal barriers.  
 Criminalization of possession of illicit substances and injecting equipment often forces 
PWID in many settings to hide their equipment and engage in unsafe injecting practices (Stoicescu, 
2012) . Findings from this assessment also suggest that the existing de facto criminalization of drug 
use, punitive approach and arrests of PWID by the law enforcement personnel, including 
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surveillance of NSP programs and using possession of clean or used syringes and needles to justify 
detentions of PWID, as well as high level of social marginalization of PWID, limited the uptake of 
NSP services by PWID.  Fears of breached confidentiality and police surveillance and interference 
around NSP sites were uniformly reported among all interviewees.   Possession of used syringes 
was reported as a factor that may increase vulnerability of PWID to police harassment, thus, making 
the requirement for syringe exchange an obstacle to more people using NSP services.  These 
findings are not unique to the Kyrgyz Republic, as criminalization of drug use and possession of 
syringes and needles was consistently reported as a common barrier to NSP utilization by several 
other studies conducted earlier in the Kyrgyz Republic (Spicer et al., 2011) and elsewhere (Beletsky 
et al., 2014; Koo et al., 2015; Martinez et al., 2007; Rich et al., 1999; Spicer et al., 2011; WHO, 
2014a).  Similarly to other countries, in the Kyrgyz Republic, PWID reported heightened sensitivity 
to discrimination and notions of identity and legitimacy that were closely linked to the 
stigmatization of drug use.  
 Lack of trust between clients and NSP staff who had no personal experience injecting drugs 
was reported as another significant obstacle for the delivery of effective NSP services for people 
who inject drugs. For this reason the secondary exchange was preferred and used by many PWID 
because if relieved the fear of exposure or possible police encounter.  This further supports the 
need to ensure active involvement of PWID in implementation of NSPs, especially considering that 
stigma, discrimination, and criminalization continue to pose significant barriers to HIV program 
access for PWID, in increasing access to healthcare (Ti & Kerr, 2013).   
 Similar to many other countries (Cattan et al., 2009; Holt, 2014; Malinowska-Sempruch, 
2015; van Olphen, Eliason, Freudenberg, & Barnes, 2009), deep-rooted conservative attitudes 
towards women's roles in society and high level of stigma against women who use drugs at all 
levels in the Kyrgyz Republic, even among PWID themselves, prevents them from using NSP 
services.  
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 At the institutional level, inconvenient working hours, unfriendly attitudes by NSP staff and 
limited menu of supplies available to clients made NSP less attractive to PWID.  
 Availability of outreach services was highly valued by PWID in this study.  The also study 
showed that additional services, such as naloxone distribution, on-site HIV testing and provision of 
surgical wound care, dental services and medicines could facilitate increases utilization of NSP 
services, which was similar to findings from other countries (Cattan et al., 2009).   
Study Limitations 
 This assessment included 19 out of 30 NSP sites located outside of the penitentiary system 
in the Kyrgyz Republic.  Although nearly a third of the sites were excluded from the assessment, 
based on discussions of preliminary results with the wide range of national partners organized 
during a national conference of current HIV issues held in March 30, 2016 it may be reasonable to 
assume that the results of this assessment can be applied to all NSP sites in the Kyrgyz Republic.  
That said, differences may be expected among PWID who are institutionalized and situated in 
different living conditions within a penitentiary compared to those who live as free citizens. 
 The ability of the study to draw definite conclusions about the effectiveness of NSP 
implementation in ensuring appropriate coverage of PWID with NSP services in a particular 
geographical area by a particular type of NSP was limited by the lack of site-level PWID size 
estimation data.  Another limitation relates to the use of secondary data collection from an existing 
database. As described in the Methods section, aggregated site-level program data routinely 
entered into a Management Information System (MIS) were used in the assessment.  These data are 
entered into the MIS by staff of the NSPs at the individual client level from reports completed by 
NSP staff, including outreach workers.  The MIS does not allow tracking of duplicate clients that 
receive similar services in different NSPs.  Also, there is a possibility for one person to be recorded 
into the MIS under the different unique identifier codes, thus leading to the inflated number of 
clients served by each site. Data quality checks for accuracy of the data in the MIS are routinely 
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conducted by the UNDP and the GFATM during on-site data verification visits. Thus, the assessment 
assumes accuracy of the data entered into the MIS, but may not accurately represent the actual 
coverage and quality of program implementation.  
 Also, a small number of NSPs included into the study, particularly pharmacy-based NSPs, 
have limited the ability to identify differences between NSP modalities that may have existed.    
 Further, the study relies on data reported by PWID during focus-group discussions, which 
may be subject to social desirability bias and over- or under-estimation of various factors 
measured.  
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CHAPTER VI. RECOMMENDATIONS AND A PLAN FOR CHANGE 
 Despite the limitations of this assessment, the study is among the first to be conducted in 
the Kyrgyz Republic, which underscores the importance of these results. The assessment allowed 
evaluating both the “forest” (national NSP policies, NSP budget, procurement supply systems, etc.), 
as well as the individual “trees” (implementation of national policies at the service-delivery level, 
PWID needs and obstacles to NSP access, staff capacity building needs, site-level infrastructure, 
etc.) (Mella, 2012).   
 Considering the comprehensiveness of the study that assessed NSP outside the penitentiary 
system, a number of policy-level recommendations can be offered to improve implementation and 
effectiveness of NSP implementation in the Kyrgyz Republic based on the findings (Table 9). 
Table 9.  Key weaknesses of the NSP program in the Kyrgyz Republic and key 
recommendations.  
# Identified gap Recommendation 
1 Limited sustainability of 
NSP program 
implementation  
To discuss the feasibility and the need to revise the Law #66 on 
Narcotics, Psychotropic Drugs and Precursors from May 22, 
1998 (revision #40 dated March 2, 2010) to include provisions 
of anonymous NSP services for people with drug dependence 
into articles #38-39 on voluntary drug treatment.  
 
To develop a clear national strategy to secure long-term and 
sufficient levels of funding to ensure sustainability of NSPs and 
the achievement of other quality standards. Long-term 
government funding should be committed to the ongoing 
operation of NSPs and detailed contingencies for funding gaps 
should be determined. Funding levels must be adequate to 
ensure high-quality NSP services, with high levels of access and 
coverage, including no restrictions on the quantity of 
equipment that can be distributed, as well as appropriate 
compensation schemes for outreach workers, including 
reimbursement of transportation costs.  
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# Identified gap Recommendation 
2 Limited geographical 
availability of services 
To scale up the number of NSP sites to ensure they are 
available at least in larger residential areas of every oblast. 
Mobile NSP can compensate for the absence of fixed NSP sites 
in more rural areas.  To ensure cost-effectiveness, NSP 
functions can be included into the scope of work for the 
already existing mobile HIV counseling and testing points that 
already exist and work with PWID in some areas.   
3 No comprehensive 
monitoring and evaluation 
plan 
To develop and officially approve a comprehensive monitoring 
and evaluation plan to track coverage and outcomes of NSP 
service delivery. The plan must list measurable outcomes, 
measurement tools, frequency of data collection, responsible 
entities, and targets.  The plan must be supported by a 
sufficient budget and staff capacity building plan, as well as 
clearly describe distribution of responsibilities for data 
collection and data quality assurance and control at the 
national and sub-national levels, as well as clear and inclusive 
data dissemination plan.  
4 Lack of systems to collect 
anonymous feedback from 
clients 
It is important to add to the National NSP Standards the 
requirement for NSP to introduce and properly document 
regular collection of anonymous feedback from clients.  
Mechanisms should be in place whereby clients can 
confidentially and anonymously provide feedback on the NSP 
services. NSPs should be responsive to this information.  
5 Limited access of PWID to 
health services due to 
stigma 
To remove compulsory registration of all people with 
diagnosed substance use disorders.  
To institutionalize training into establishment of PWID-
friendly services into the routine training of NSP staff, health 
professionals and police forces with the aim to ensure that the 
drug use is treated as a health condition and less as a moral 
behavior, and more generally to focus efforts on stigma 
reduction among health providers, law enforcement, and the 
community at large.  To be effective, the trainings need to 
include direct contacts of trainees with PWID (Livingston, 
Milne, Fang, & Amari, 2012).  
6 Low utilization of low-
dead space syringes 
To expand availability and use of low-dead-space syringes.   
Informational sessions for NSP staff, especially outreach 
workers, and pharmacy workers that participate in NSP on the 
benefits of LDSS use must be conducted to ensure NSP staff 
have sufficient knowledge of LDSS and are able to motivate 
PWID.   It is also important for NPS to develop short and 
illustrative educational and informational materials, 
motivating PWID to shift from HDSS to LDSS.   To improve 
acceptability of LDSS among PWID it is also important to 
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# Identified gap Recommendation 
ensure procurement and dissemination of larger volume (2 ml) 
syringes with detachable needles, and separately different 
length low-dead space needles that could be used with HDSS.  
7 Lack of established 
referral pathways 
between NSP and other 
relevant health services 
To link NSP programs to OST and ART programs for PWID in 
order to achieve decrease in HIV incidence.  NSP staff should be 
properly trained and encouraged to actively refer their clients 
for OST programs.  They should also be trained on HIV status 
disclosure and HIV care and treatment adherence support.  
Education and communication materials on OST and ART must 
be developed and made available for outreach workers and 
NSP clients.   Referrals to OST and ART should be documented, 
tracked and reported to encourage integration of services 
8 Limited HIV testing of NSP 
clients 
To significantly increase the coverage of PWID that use NSP 
services with HIV testing and counseling.  NSPs should use any 
opportunity to counsel PWID about HIV testing and either 
conduct on-site HIV rapid testing, draw blood for ELISA testing 
if rapid tests are not available, or ensure assisted referral of 
their clients for HIV testing.  On-site HIV rapid testing should 
be promoted and supported.  It is also important that the HTC 
data is properly documented by NSP staff to facilitate program 
monitoring, track performance of outreach workers and 
encourage service improvements. 
9 Limited activities to 
prevent sexual 
transmission of HIV 
among PWID 
To utilize couple-based approaches to HIV prevention in order 
to ensure effective prevention of HIV sexual transmission 
among PWID and their partners. PWID and their sex partners 
should be provided with information regarding effective HIV 
prevention methods. Providers, including outreach workers 
must be trained on facilitated disclosure and encouraging 
PWID to refer their sex partners for HIV testing. PWID should 
be encouraged to engage their sex partners in HIV programs 
which may include regular HIV testing, information on 
prevention methods, supportive counseling and condom use 
promotion.  
10 Limited network of 
trained outreach workers 
To establish an appropriate compensation scheme, including 
reimbursement of transportation costs, and increase the 
number of outreach workers per NSP as outreach workers are 
essential for the effective implementation of the NSP in the 
Kyrgyz Republic.   
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 In order to transform the listed-above recommendation into meaningful policy and service 
delivery change, it will be important to first establish a sense of urgency and form a powerful 
guiding coalition that will work towards creating and communicating a vision of NSP program 
improvement and empower others to act on the developed vision (Kotter, 1996).   The proposed 
below activities aim at establishing a sense of urgency and creating such coalition.  
 Activity 1 – Comprehensive Assessment Report.  In order to disseminate findings of this 
report and create urgency I will develop a comprehensive assessment report in Russian and English 
that will be disseminated to all organizations that work with PWID in the Kyrgyz Republic.  
Specifically, the distribution list will include the Ministry of Health, key donor organizations that 
fund NSP activities (the GFATM and the PEPFAR team (USAID and CDC)), multilateral organizations 
(UNAIDS, UNODC and WHO), as well as PWID-servicing NGOs and government NSP service 
providers. The hope is that these groups would use the results and recommendations from the 
report to reach and influence the policymakers and funders and advocate for removal of the 
existing barriers to PWID uptake of services, namely the compulsory registration of all PWID with 
narcological services.   
 Also, I hope that the NSP service providers will implement specific recommendations of this 
study that don’t require additional funding or policy change to improve the quality of their services.  
For example, NSP service providers can change NSP working hours, institute programs or trainings 
to sensitize NSP staff to PWID needs and build their capacity to provide more user friendly services, 
utilize couple-based approaches to HIV prevention and increasing HTC and referral efforts. Also, the 
Republican AIDS Center has agreed to place a copy of the assessment report on its website which 
demonstrates political commitment of the Kyrgyz Government to improve NSP program.   
 Activity 2 – Dissemination of tailored presentations.    I will develop summary 
presentations tailored to various audiences on the process, findings and recommendations of this 
study.    The arrangements have already been made to present key results of the study during the 
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national roundtable on “Current issues of HIV program implementation in the Kyrgyz Republic” 
that will be organized by the Ministry of Health together with ICAP at Columbia University in May 
2016.  A separate presentation will be delivered to the Central Asia PEPFAR team during the 
internal Regional Operations Plan (ROP) planning meeting to justify allocation of funds for 
enhanced technical assistance.   The summary findings will also be presented to the National 
Technical Working group.  
 Activity 3 – Support to the National Technical Working Group (TWG).  Active 
involvement of key stakeholders in the discussion of study findings and development of a specific 
"road map" on how to implement recommendations from this study and improve quality of NSP 
programs in the country is vital to ensure country ownership and institutionalizing of 
recommended changes.   ICAP will technically and financially support the work of the national TWG, 
that will include representatives from the entities under the Ministry of Health mandated to work 
on HIV prevention among PWID (Republican Narcology Center and Republican AIDS Center), 
representatives of the national networks of local NGOs that work with PWID (NGO Partnership 
Network and the Public Association on Social Development and Human Adaptation) and 
representative of the Public Health Department within the Ministry of Internal Affairs.  Staff from 
the international and donor organizations, including UNDP/GFATM, CDC and USAID, will also 
participate in the work of the national TWG.  The goal of the TWG would be to use 
recommendations from this assessment to develop a comprehensive quality improvement and 
capacity building plan.  The plan should describe the specific responsibilities of different 
stakeholders involved in NSP and funding options.  This plan will be submitted to the Ministry of 
Health for further endorsement and enforcement.  Implementation of the “road-map” 
recommendations will be tracked and regularly presented during relevant partner meetings and 
the Country Coordination Mechanism meetings to ensure appropriate follow-up actions.   
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 Activity 4 – Trainings for Healthcare Workers.   In order to address limited access of 
PWID to health services due to stigma, ICAP will collaborate closely with CDC and the Kyrgyz 
University for Continuous Medical Education on the development and implementation of the 
national sensitization trainings for health care providers, including physicians and nurses.  The 
overall goal of the trainings will be to address barriers PWID face when trying to access healthcare 
services by sensitizing health care providers to the unique context and needs of key populations in 
general and PWID in particular.  Key objectives of the training will include:  
 Sensitize health care providers to deliver HIV and HIV-related services to all clients, 
particularly to PWID, in a non-stigmatizing and competent manner 
 Increase competency of healthcare workers at providing comprehensive, non-stigmatizing 
services to PWID 
 Increase quality of care by tailoring services to specific PWID needs, ultimately resulting in 
increased use and retention 
 In addition to the proposed above policy-level activities, I will also work to secure funding 
and pilot a model of improved NSP implementation that will include:  
1. Supplement one of the existing facility-based NSP with distribution of clean syringes 
and needles, including LDSS, through a syringe vending machine (SVM) which will allow 
24/7 access of PWID to free-of-charge clean needles and syringes;  
2. Active utilization of couple-based approaches to HIV prevention in order to ensure 
effective prevention of HIV sexual transmission among PWID and their partners.    
3. Implementation of on-site HIV rapid testing in order to increase the coverage of PWID 
that use NSP services with HIV testing and counseling. 
4. Improved linkages and an established referral system between the NSP and various 
health services, including HIV care and treatment, OST, STI, and tuberculosis diagnosing 
and treatment. 
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 As part of the pilot an SVM will be installed outside of the entrance to the one of the existing 
facility-based NSPs in Bishkek city located in the area known for high concentration of PWID.  The 
objective of the SVM would be to allow PWID that do not want to use commercial pharmacies or 
fixed NSP sites to get clean injecting equipment after hours.  To use SVM PWID would require 
special tokens that will be distributed at the NSP sites.   In order to ensure regular face-to-face 
interactions with trained NSP staff, NSPs will provide their clients with up to 30 tokens at every 
visit.  SVMs dispense packs will contain sterile injecting equipment and a small disposal container.  
The type of injecting equipment to be included in the dispense packs will be defined based on the 
information received during focus groups with PWID.  Packs dispensed will also include swabs, 
water ampoules, condoms and educational materials.  
 Also, PWID and their sex partners will be provided with information regarding effective HIV 
prevention methods. Providers, including outreach workers will be trained on facilitated disclosure 
and encouraging PWID to refer their sex partners for HIV testing. PWID will be encouraged to 
engage their sex partners in HIV programs which may include regular HIV testing, information on 
prevention methods, supportive counseling and condom use promotion.   The pilot will include 
targeted promotion of NSP activities, including the SVM, and active engagement of PWID in NSP 
services through outreach workers and using peer-driven intervention (PDI) approach. The PDI 
model is based on the theory of ‘‘group-mediated social control’’ (Heckathorn, 1990) that has been 
proven as an effective approach to reaching larger and diverse sub-populations of PWID with HIV 
prevention efforts in different settings (Broadhead et al., 1998; Smyrnov, Broadhead, Datsenko, & 
Matiyash, 2012; Tun et al., 2013). The pilot will include comprehensive monitoring and evaluation.  
In case of the successful piloting, I will advocate to the Ministry of Health and the GFATM to allocate 
resources for scaling up of the pilot intervention to other NSP sites.   
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APPENDIX 1: INDIVIDUAL IN-DEPTH INTERVIEW GUIDE FOR NSP PROGRAM MANAGERS 
Date of Interview  
Name/location of NSP  
Gender  
Number of years 
working in NSP 
programs 
 
 
1. Can you describe the process that is used by your NSP to inform decisions about the 
 location, operating hours, commodities provided and services provided at this site? 
2. Do you solicit regular feedback from your clients and involve them in program 
 planning and improvement? Do you solicit regular anonymous feedback from 
 clients? Please describe the process.  
3. Do you involve PWID in the delivery of NSP services?  If Yes, please explain how and 
 how do you ensure appropriate training WPID that you involve in service provision? 
 If not, please explain why. 
4. Do you tailor your services to needs of any specific sub-group of PWID, for example 
 female PWID?  If yes, how?  If not, why?   
5. Did you and other staff currently working at this NSP receive any special training 
 related to NSP implementation?  If yes, please describe the training received (where, 
 who, what topics were covered).
6. Do you feel there is a need for any additional training or professional development 
 for you or your staff to better perform functions at the NSP?  If yes, in what areas? 
7. Can you describe what commodities are available at your site? And how do you 
 know that the available commodities are appropriate and acceptable for your 
 clients?  
8. How do you manage procurement and supply of injecting equipment? Who is 
 responsible for the forecasting and planning? What do you do to prevent stock-outs?  
 Did your site experience any stock-outs during the past year?   
9. Do you have any specific written guidelines for distributing needles and syringes to 
 consumers?  
a. Please describe the process for distributing needles and syringes and other 
 commodities to consumers at this site.  
b. Do you charge consumers for any of the commodities you distribute? If yes, 
 how much and for what? 
c. Do you have any set limits on the quantity of injecting equipment provided 
 to one client?  
d. Do you allow for secondary distribution/exchange?   If yes, how do you 
 record the number of PWID reached through the secondary distribution? 
e. Do you have outreach services to disseminate commodities?  How many 
 outreach workers do you have?  How do you recruit outreach workers?  
 What are the key challenges related to implementation of outreach services?  
10. Do you have any specific policies or guidelines on used needle and syringe return?  
 Do you collect used needles and syringes, if yes, how? What are your disposal 
 practices?  
11. How do you ensure confidentiality of your clients?  
 73 
12. Please describe the referral processes your NSP have to link consumers with other 
 health services.  Are those referrals formalized by any agreements between the NSP 
 and the services providers that you refer your clients to? Do you verify if clients 
 referred have been enrolled/received services referred to? If yes, describe how you 
 do this? Do your clients need to pay for any of the referral services, please specify.  
13. Do you feel services to which clients are referred are sensitive, supportive and easily 
 accessible to your clients?  
14. How do you support, follow-up and track referrals?    
15. Please rate and comment on how effective you think your NSP is in engaging people 
 who inject drugs: 
 Very effective 
 Effective 
 Not effective 
 Somewhat effective 
 Don’t know 
Comments:  
_____________________________________________________________________________________________________________
16. What factors make it difficult for your NSP to engage people who inject drugs?  And 
 how do you think you could improve the access for PWID? 
17. Please rate and comment on how effective you think your NSP is in engaging sex 
 partners of people who inject drugs: 
 Very effective 
 Effective 
 Not effective 
 Somewhat effective 
 Don’t know 
 
Comments: ___________________________________________________________________________________________ 
 
18. What do you think are the key features of an effective NSP service? 
19.  What are the internal barriers to operating an NSP that impact on service demand 
 and the types of services provided?  
20. What are the external barriers to operating an NSP that impact on service demand 
 and the types of services provided? 
21. What are the strengths and weakness of your NSP service? Describe any 
 improvements needed.  
22. What additional resources are needed for your NSP to enhance the quality of 
 services?  
23. How effective on the scale from 1 – 5 where 1 is not effective and 5 is very effective 
 is your NSP in  
Promoting safer injecting practices    ____ 
Ensuring regular frequent HIV testing   ____ 
Ensuring regular TB screening    _____ 
Making sure customers know their HIV test results ____ 
Linking HIV-positive PWID to HIV care services ____ 
Referring your clients to MAT services  _____ 
Improving adherence of HIV-positive PWID to  
HIV care and treatment     ____ 
Promoting safe sexual behavior    ____ 
 74 
APPENDIX 2: GUIDE FOR THE FOCUS GROUP DISCUSSIONS WITH PWID 
Introduction:  People who inject drugs are at high risk of acquiring HIV infection. Syringe 
distribution is an effective HIV prevention method. Syringe and needle programs have been 
implemented in The Kyrgyz Republic since 2002.  We are conducting this assessment to understand 
what works and what does not work with the current implementation of the program and what needs 
to be done to make needle and syringe programs more accessible and effective for people who inject 
drugs.  
 
ICE-BREAKER QUESTIONS (up to 5 minutes per question) 
1. What services are provided by the needle- syringe exchange program? Probe: 
a. Free of charge needles and syringes 
b. Free condoms 
c. HIV counseling and testing 
d. Referral to other health services 
 
2. What services provided by the needle- syringe exchange program do you think are 
 the most useful for PWID?  
 
KEY QUESTIONS (up to 12 minutes per question) 
 
3. What do you think are the most significant reasons why some drug users choose not 
 to use needle and syringe programs? Probe:  
e. What is the attitude of law enforcement personnel/police towards PWID 
 using NSP? 
f. What are the criteria for PWID to access services set by NSP?  
g. Range of syringes and needles available?  
h. Confidentiality concerns? 
 
4. Do you know women PWID that do not use NSP services?  Why are they not using 
 NSP services?  
 
5. What can be done to improve the quality of needle and syringe distribution 
 programs and access to HIV services uptake? 
a. Location? 
b. What are the most convenient open hours?  
c. What modalities are the most convenient for you?  Mobile services, 
 pharmacy-based distribution?  
d. Secondary needle and syringe distribution?  
 
6. Can you think of anything else you would like to share with the group on this 
 subject, that hasn’t already been covered? 
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APPENDIX 3: SURVEY FOR THE FOCUS GROUP PARTICIPANTS 
For the purpose of our research, we need to describe who participated in our focus groups.  Please help 
us by answering the following questions.  DO NOT include your name.  Your responses to the survey are 
completely private and confidential. 
 
 
1. Date __________________________ 
 
2. UIC  |___|___|___|___|___|___|___| 
 
3. Gender (Check one) 
____ Male 
____ Female  
 
4. Age:_____ 
 
5. Number of years injecting drugs 
____ None  
____ 1-5 years  
____ 6-10 years 
____ more than 10 years 
 
6. During the past two months I have used the following sites to receive clean 
needles and syringes 
 
1. ____ needle- syringe program located at the family health center 
2. ____ needle- syringe program located at the NGO 
3. ____ received them free of charge in exchange for the voucher in the 
pharmacy 
4. ____ received them from the outreach worker  
5. ____ purchased them from the pharmacy 
6. ____ other, please specify __________________________ 
 
 
  
7
6
 
APPENDIX 4: NSP PROGRAMMATIC DATA REVIEW FORM  
Measurable outcome 
level of 
disaggregation 
si
te
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si
te
 6
 
si
te
 7
 
si
te
 8
 
si
te
 9
 
si
te
 1
0
 
si
te
 1
1
 
si
te
 1
2
 
Total number of sterile injecting 
units (1 needle and 1 syringe) 
distributed in the last 12 months 
male 80483 77877 386400 97508 267596 169406 64011 114489 105318 215514 652727 95295 
female 29943 25543 32007 30548 76210 48358 2189 19767 3467 5916 46931 11340 
≤18 years  0  0 0  0  0   0 0   0  0  0  0  45 
>18 and <25 years 9724 3973 24840 2355 4629 18733 242 1290 4745 3770 29728 58590 
≥ 25 years 100702 99447 393567 125701 339177 199031 65958 132966 104040 217660 669930 48000 
HDSS 98729 96217 384890 120459 322309 206489 55700 127156 100093 187554 696658 71090 
LDSS 11697 7203 33517 7597 21497 11275 10500 7100 8692 33876 3000 35545 
Total number of PWID who 
accessed an NSP at least once 
over a 12 month period 
male 477 331 836 225 467 479 140 199 241 669 2491 916 
female 138 152 90 75 128 143 5 32 8 23 198 91 
≤18 years 0 1 0 0 0 0 0 0 0 0 0 1 
>18 and <25years 71 24 56 8 7 53 2 2 9 12 136 497 
≥ 25 years 544 458 870 292 588 569 143 229 240 680 2553 509 
HDSS 390 272 960 297 595 621 145 231 214 641 2386 891 
LDSS 341 203 925 278 595 400 144 230 186 601 911 891 
Number of PWID who were 
reached by an NSP at least once in 
the past 6 months 
male 589 322 841 275 542 381 108 187 241 387 1892 528 
female 121 150 104 84 139 102 3 29 8 17 127 72 
Number of PWID who accessed 
an NSP at least once per month 
(regular reach) over a 6 month 
period  
male 289 137 665 212 422 299 107 121 185 272 820 93 
female 72 38 77 72 108 77 3 26 12 10 50 20 
Number of eligible PWID tested 
for HIV by NSP on-site during the 
last 6 months  
male 0 0 171 0 0 0 0 0 0 28 66 0 
female 0 0 27 0 0 0 0 0 0 5 11 0 
Number PWID referred by NSP 
for HIV testing and counseling 
during the last 6 months  
male 152 28 51 83 86 106 53 61 74 27 124 205 
female 23 27 9 28 24 37 2 17 4 4 14 33 
Number PWID referred by NSP to 
MAT during the last 6 months 
male 0 0 81 2 0 1 0 1 3 0 8 0 
female 0 0 4 0 0 0 0 0 0 0 0 0 
Number PWID referred by NSP to 
STI services during the last 6 
months 
male 138 0 1 40 65 65 0 16 39 18 21 172 
female 22 0 0 16 16 20 0 5 2 7 3 32 
Number of condoms distributed 
by an NSP per PWID during the 
last 12 months  
male 16768 15831 81632 7598 42938 15003 8226 13962 10751 48206 104496 6353 
female 6094 5238 6781 2392 12177 3966 296 2408 342 1864 7690 756 
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